The present disclosure generally relates to the field of healthcare data management and in particular to facilitating data analytics for use with dose order record information such that specific, limited access to a multidimensional repository of data is provided, for example, based on a facility corresponding to a user of the tool and data related to the facility.
Healthcare facilities such as hospitals or the like often provide dose order information to a pharmacy in connection with a request to prepare a dose order record for administration to a patient. Traditional approaches to processing the dose orders received at a pharmacy included, for instance, printing physical labels for each dose order to be prepared. In turn, any activity in the pharmacy in relation to the dose orders was premised on the use of the physical labels for workflow management. In addition to the susceptibility for such physical labels to be lost, misplaced, or confused, the ability for pharmacy staff to organize, manage, or communicate the dose orders represented by the physical labels was limited.
In addition to the limitations of traditional approaches in connection with the preparation of dose orders at a pharmacy, the ability to quantify, track, and otherwise review pharmacy activity after preparation of the dose orders was also limited. For instance, the use of physical labels, which would be attached to the dose order upon completion of the preparation, left no means for logging or auditing the activities performed in the pharmacy in relation to specific dose orders absent tedious manual recordation of pharmacy work. Manual recordation of pharmacy work is time consuming, prone to error, and unreliable, and thus does not present a viable option for quantifying, tracking, and reviewing pharmacy activity. In turn, valuable information in relation to the activity of the pharmacy was not visible to pharmacy or hospital management.
Pharmacy workflow management applications have been developed to assist in the preparation, tracking, organization, and documentation of dose orders that are to be prepared or have been prepared by a pharmacy or the like. For example, co-owned U.S. patent application Ser. No. 14/022,415 entitled “MANAGEMENT, REPORTING AND BENCHMARKING OF MEDICATION PREPARATION” filed on Sep. 10, 2013, the entirety of which is incorporated by reference in its entirety. In this regard, dose order records that include received and/or appended dose order information and/or dose order metadata may be generated and stored at a facility that prepares dose orders for administration to a patient. Additionally such dose order records may be stored at a central server that is in operative communication with a plurality of facilities. In this regard, dose order records from a plurality of facilities may be collectively stored at the central server (e.g., for purposes related to data back up or the like).
In view of the foregoing, it has been recognized that dose order information from a plurality of facilities that is stored at a central location (e.g., a central server) may be advantageously utilized to provide reporting, metrics, or the like with respect to the stored data related to one or more facilities. Specifically, a data analytics tool may be provided that is in operative communication with the central server that may access the data stored at the central server to provide data analytics (e.g., dynamic reports or the like). As the data analytics tool may access the data at the central server, such analytics may be provided in relation to one or more facilities without each individual facility having to maintain an interface to the data analytics tool. However, as the data at the central server may include data from a plurality of different facilities, it has also been recognized that providing selective access to such report may advantageously allow for centralized application of a data analytics tool while maintaining security and restricted access to individuals from respective ones of the facilities when accessing data at the central server.
As such, the present disclosure describes healthcare data management that provides the ability to provide data analytics tools for use in relation to multidimensional data regarding dose order records. Specifically, the present disclosure contemplates allowing selective access to a multidimensional data set. For instance, dose order records from a plurality of facilities may be collectively stored as a multidimensional data set. A base data cube class definition may be generated that uses an identification of a user accessing the tool to determine a subset of the records to which the user has access. In this regard, the base cube class definition may have a data dimension that allows the filtering of data records for presentation to a user in a dynamically generated report. In this regard, additional data cube class definitions may inherit from the base data cube class definition so that a user may only retrieve report data corresponding to data to which they are authorized for access.
In this regard, a first aspect includes a method for providing a user selective access to a data analytics tool for processing a multidimensional data set corresponding to dose order records for use in providing data analytics to the user regarding a subset of the dose order records of the multidimensional data set. The method includes storing a multidimensional data set comprising information corresponding to a plurality of dose order records. The plurality of dose order records of the multidimensional data set comprises at least one indication of a facility corresponding to the dose order records. The multidimensional data set comprises dose order records corresponding to a plurality of facilities. The method further includes receiving user information from a user at one of the plurality of facilities. The user information is indicative of a given facility from which the user is accessing a data analytics tool. The method also includes providing the data analytics tool access to the multidimensional data set to generate a dynamically generated report regarding a subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool. Additionally, the method includes presenting to the user at a user interface the dynamically generated report regarding the subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool.
A number of feature refinements and additional features are applicable to the first aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the following features that will be discussed may be, but are not required to be, used with any other feature or combination of features of the first aspect.
For instance, in an embodiment the data analytics tool may include a plurality of data cube class definitions applicable to the multidimensional data set to generate the dynamically generated report. The plurality of data cube class definitions may include a base cube class definition from which all others of the plurality of data cube class definitions depend. The base cube class definition may include at least one data dimension related to the at least one indication of a facility corresponding to the dose order records. In turn, the method may include applying the base cube class definition to the multidimensional data set based on the user information indicative of a given facility from which the user is accessing the data analytics tool and building a data cube based on the applying that limits the data accessible by the user to the subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool.
In an embodiment, the building may include performing at least one data transformation operation on the subset of the multidimensional data set, wherein the at least one data transformation operation is defined in the base cube class definition. The at least one data transformation may include automatically transcribing a first data field for each given dose order record in the subset with a second data field of the respective ones of the dose order records of the subset. The at least one data transformation may be applied only to a given type of dose order records. The type of dose order records may be total parenteral nutrition (TPN) doses, the first data field may be a dose description field, and the second field may be a drug name field for the given dose.
In an embodiment, the method may further include invoking another of the data cube class definitions depending from the base cube class definition for application to the subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool to generate the dynamically generated report regarding the subset of the multidimensional data set. In certain applications, the plurality of data cube class definitions may include a parameter indicative of whether data cubes built using the data cube class definitions include protected health information (PHI). The parameter may be dynamically generated based on at least one dimension of the data cube class definition.
In an embodiment, the receiving may include receiving login information at a local server resident at the facility from which the user is accessing the data analytics tool to initiate a user session, authenticating the user to a central server based on the login information received at the local server, and populating a session variable related to the user session based on authenticated user login information. The session variable may include the user information indicative of the given facility from which the user is accessing the data analytics tool. In this regard, the method may include a delegated authentication process that may, in at least some applications, include passing a token at least partially based on the session variable to the data analytics tool. The token may be compared to available tokens at the central server to determine if the user is to be granted access to the data analytics tool. Accordingly, upon matching the token to one of the available tokens, the token may be issued to the user and the corresponding available token is removed from the central server. In some applications, the session variable includes a role definition for the user generated based at least in part on the login information received by the user. The role definition may include indications as to the ability of the user in relation to viewing reports, editing reports, viewing cube class definitions, editing cube class definitions, viewing pivot tables, editing pivot tables, viewing dashboards, and editing dashboards.
The method may further include logging user activity in relation to the use of the data analytics tool by the user. The logging may include recording information regarding the user and the usage of the data analytics tool by the user. The logging may include recording the identity of the dynamically generated report presented to the user. The logging may include recording whether the dynamically generated report presented to the user contained protected health information (PHI). The multidimensional data set may include data regarding the identity of doses, data regarding the steps of preparing the doses, data regarding the timing of doses, data regarding errors that occurred during dose preparation, data regarding product waste, data regarding drug usage, data regarding drug therapies administered, and data regarding drug interactions.
A second aspect includes a system for implementation of a data analytics tool for processing a multidimensional data set corresponding to dose order records for data analytics regarding a subset of the dose order records of the multidimensional data set. The system includes a central server that is in operative communication with a plurality of local servers, each of the local servers being disposed at a corresponding respective facility that prepares doses corresponding to dose orders for administration to a patient. The central server receives information regarding dose order records corresponding to the dose orders from the local servers. The system also includes a database at the central server that stores a data structure comprising a multidimensional data set including a plurality of dose order records received from the plurality of local servers. Each of the plurality of dose order records of the multidimensional data set comprises at least one indication of the facility from which the dose order record was received. The system may also include a local server interface in operative communication with the plurality of local servers for receiving from at least one of the plurality of local servers user information from a user at one of the plurality of facilities. The user information is indicative of a given facility from which the user is accessing a data analytics tool. The system also includes a data analytics interface that facilitates operative communication with a data analytics tool. The data analytics interface provides a data analytics tool access to the multidimensional data set stored in the database to generate a dynamically generated report regarding a subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool based on the user information received from the local server interface. The system also includes a user interface for presenting to the user at a user interface the dynamically generated report regarding the subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool.
A number of feature refinements and additional features are applicable to the second aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the features discussed above in connection with the first aspect may be, but are not required to be, used with any other feature or combination of features of the second aspect.
A third aspect includes a system for providing a user selective access to a data analytics tool for processing a multidimensional data set corresponding to dose order records for use in providing data analytics to the user regarding a subset of the dose order records of the multidimensional data set. The system includes a central server that is in operative communication with a plurality of local servers, each of the local servers being disposed at a corresponding respective facility that prepares doses corresponding to dose orders for administration to a patient. The central server receives information regarding dose order records corresponding to the dose orders from the local servers. The system also includes a database at the central server that stores a data structure comprising a multidimensional data set including a plurality of dose order records received from the plurality of local servers. Each of the plurality of dose order records of the multidimensional data set comprises at least one indication of the facility from which the dose order record was received. The system also includes a local server interface in operative communication with the plurality of local servers for receiving from at least one of the plurality of local servers user information from a user at one of the plurality of facilities. The user information is indicative of a given facility from which the user is accessing a data analytics tool. The system also includes a data analytics tool in operative communication with the database for access to the multidimensional data set stored in the database to generate a dynamically generated report regarding a subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool based on the user information received from the local server interface. The system also includes a user interface for presenting to the user at a user interface the dynamically generated report regarding the subset of the multidimensional data set corresponding to the given facility from which the user is accessing the data analytics tool.
A number of feature refinements and additional features are applicable to the third aspect. These feature refinements and additional features may be used individually or in any combination. As such, each of the features discussed above in relation to the first aspect may be, but are not required to be, used with any other feature or combination of features of the third aspect.
The following description is not intended to limit the invention to the forms disclosed herein. Consequently, variations and modifications commensurate with the following teachings, skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described herein are further intended to explain modes known of practicing the invention and to enable others skilled in the art to utilize the invention in such, or other embodiments and with various modifications required by the particular applications(s) or use(s) of the present invention.
With reference to
Accordingly, in at least one embodiment, the facilities 14 may comprise unaffiliated and discrete healthcare facilities 14 capable of preparing medication doses for administration to patients. The central server 12 may be hosted by another discrete and unaffiliated third-party that may be separate from any of entities of the facilities 14. For instance, the central server 12 may be hosted and/or executed by an application provider that provides one or more client applications for execution by the facilities 14 to facilitate a pharmacy workflow management application. Specifically, the central server 12 may be executed or hosted by an application provider that provides the pharmacy workflow management application each facility 14.
As such, the facilities 14A, 14B, and 14C may execute a pharmacy workflow management application that may allow for the facilities 14A, 14B, and 14C to receive, process, organize, prepare, track, or otherwise manage dose orders to be prepared at each of the respective facilities 14A, 14B, or 14C. In this regard, each facility 14 may generate dose order information related to dose orders processed at each respective one of the facilities 14. In turn, facilities 14 may be in operative communication with the central server 12 and may provide dose order data to the central server 12.
In this regard, dose order data may include any one or more classes of information regarding dose orders processed. For instance, the dose order data may include information corresponding with the dose order received at the pharmacy (e.g., including information entered by way of a physician order entry (POE) system, received by a pharmacy information system (PhIS), or the like). The dose order data may also include data appended to and/or generated in connection with the preparation of a dose order. This information may include data related to the products (e.g., drug products, pharmacy products, or hardware) used to prepare the dose order. As such, the information may include information regarding one or more drugs (or all drugs) used to prepare the dose such as a national drug code (NDC), a lot number, and expiration, etc. The information may also include preparation metadata such as information related to the identity of personnel taking action with respect to a dose, time events related to a dose, images associated with dose preparation and/or verification, errors that were detected or occurred during dose processing, information related to a pharmacist review of a dose, tracking information regarding a dose in the pharmacy and/or administration environment, etc. In short, the dose order data may comprise any information regarding the dose order or preparation of the dose order that is recorded, generated, appended, or otherwise associated with the dose order.
Additionally, a data analytics server 16 may be operative communication with the central server 12. As will be discussed in greater detail below, the data analytics server 16 may comprise a data analytics tools that may be applied to data at the central server 12 to generate, for example, dynamically generated reports for use in data analytics with respect to the data to which the data analytics tool is applied at the central server 12. The data analytics tool may include data cube class definitions that define data organization and transactions carried out with respect to data to facilitate generation of dynamic reports for use in data analytics. Such data cube class definitions are described in greater detail below. In any regard, it may be appreciated that the data cube class definitions may be applied to data at the central server 12 to facilitate data analytics with respect to the data to which the data cube class definitions provided by the data analytics tool as applied.
As such, users from each respective facility 14 may be operative to access the data analytics tool provided by the analytics server 16 to invoke the data analytics tool for use in connection with data stored on the central server 12. As outlined briefly above, while provision of the data analytics server 16 in operative communication with the central server 12 may simplify the interface complexity of the system 10 (e.g., in contrast providing a data analytics server connection directly to each facility), the interface with a central server 12 may result in the need to provide selective, secure access to the data stored in the central server 12. Specifically, as the central server 12 may store data from a plurality of facilities 14, it may be that users from a given facility (e.g., the first facility 14A) should not be provided access to data from other facilities (e.g., the second facility 14B or third facility 14C). That is, selective access to users may be provided such that users of a given facility may only be provided access to data analytics with respect to data for the facility from which the user is accessing the data analytics tool. In this regard, the system 10, as described in greater detail below, may provide selective, secure access to a data analytics tool with respect to a portion of data specific to the facility 14 from which the data analytics tool is accessed.
While the following disclosure mentions providing selective access on a facility by facility basis by determining a facility from which a user is accessing the data analytics tool, it may be appreciated that a user accessing the tool from a given facility may be an organizational user. That is, a plurality of facilities may comprise an organization. As such, a user accessing the tool from a given one of the facilities comprising the organization may have credentials sufficient access data from the plurality of facilities comprising the organization. Thus while potentially referenced herein as a facility by facility determination of access to data, the system may be executed such that any data at the central server may be analyzed using the data analytics tool so long as a user accessing the tool has sufficient credentials to view the data and utilize the tool.
The local dose order data 22 may be provided from the local server 20 to the central server 12. In this regard, the central server 12 may store aggregated local dose order data 24. For instance, the aggregated local dose order data 24 may include dose order data received a plurality of facilities as illustrated in
As described above, it is been recognized that the provision of a data analytics tool relative to aggregated data at the central server 12 may provide attendant efficiencies in that a single interface with respect to the central server 12 may be maintained such that interfaces between each given facility 14 and a data analytics server 16 need not be provided or maintained. As such and for example, development of new data cube class definitions 26 may be provided to all users of the data cube without having to specifically develop such cubes for use by each facility 14 individually. However, in connection with performing data analytics on the aggregated local dose order data repository 24, it may be necessary to provide a mechanism that allows for users from respective ones of the facility to access only data at the central server 12 to which the user has corresponding credentials to view. Otherwise, data integrity with respect to each individual one of the facilities 14 may be lost.
Accordingly, as contemplated herein, a user authentication process may be provided whereby a user may be required to provide user information that may in turn be used to determine a facility from which the user is accessing data analytics tool. Based upon the user identification information, the determination of the data to which the user has access may be appropriately limited to data corresponding to the facility (or organization) corresponding to the user. Accordingly,
Initially, with respect to
The user workstation 18 may initially display a pharmacy workflow management login screen 28. One such example of a pharmacy workflow management login screen 28 is depicted in
Accordingly, the user name and password combination entered into the user name field 500 and password field 502 may comprise user authentication information. The provided user authentication information 38 may be communicated to the local server 20. In turn, the local server 20 may process the provided user authentication information (e.g., in reference to the record of authorized username password combinations) to determine whether the user attempting to access the system 10 is authorized to do so. If the user is so authorized (e.g., the user name and password combination provided matches an authorized username password combination stored in the repository the local server 20), the local server 20 may initiate a response 40 that comprises information related to a pharmacy workflow home screen 30. The response 40 may provided to the user workstation 18 such that the pharmacy workflow home screen 30 is displayed to you user workstation 18.
With further reference to
Accordingly, the central server may utilize the authentication information 44 to authenticate the user is having appropriate permissions to access the management reports tool at the central server 12. In turn, the central server 12 may return an authentication key 46 to the local server 20. The local server 20 may in turn provide a redirect command 48 to the central server 12. Upon receipt of the redirect command 48 at the central server 12, the central server 12 may provide a redirection command 50 to the user workstation 18 that redirects the user workstation 18 to a central report screen 32 provided by the central server 12. An example of the central report screen 32 is depicted in
Additionally, if access the data analytics server 16 is authorized for the given user accessing the central report screen 32, a link 506 to the analytics tool may be provided. The link 506 at the central reports screen 32 may be selected to generate a request 52 for access to an analytics report listing page. In this regard, upon selection of the link 506, the request 52 may be provided to the central server 12 requesting the analytics report listing from the central server 12. In turn, the central server 12 may redirect the user to the data analytics report list screen 34 by providing a redirect command 54 to the user workstation 18. An example of a data analytics report listing screen 34 is provided in
The data analytics report listing screen 34 may provide the reports 508 in an organized fashion. In this regard, the links 508 to the reports may be provided in a report listing 510. The report listing 510 may include categories 512 that may be arranged in folders 514 for organization of the report links 508. A folder 514 may be generated that may be specific to a given facility and/or given user. In this regard, with the appropriate responsibility or role, a user may be operative to save a copy of a data cube and/or a report generated based on a data cube into the user or facility specific folder. In this regard, a user may be operative to modify the resulting report as desired when saving to the folder. The modifiable report may be saved in a nonpublic folder for access by only that given user or users from a particular facility. Upon selection of a link to report name 508, a request 56 may be provided to the central server 12 requesting the report.
Upon receipt of the request 56 for a selected report 508, the central server 12 may provide authentication information 58 to the data analytics server 16 to authenticate the user. For instance, the authentication information 58 may comprise or be at least partially based upon user information provided login 38. Upon authentication of the user to the data analytics server 16, a data cube class definition corresponding to the selected report may be invoked and applied to data at the central server 12. In this regard, the requested analytic report may have a corresponding data cube class definition is maintained at the data analytics server 16 that may be provided to furnish the requested analytic report. In this regard, the data cube class definition may be provided 60 to the central server 12 for application to data maintained at the central server 12 to facilitate provision of the requested analytics report by a communication 64 of the report to a data analytics report display screen 36. One such example of the data analytics report display webpage 36 shown in
The data analytics report display screen 36 may be populated with the requested data analytics report 64 return to the user workstation 18. In the example provided in
As described briefly above, the reports that may be delivered for display in a data analytics report display screen 36 may be at least partially derived upon application of a data cube class definition to data at the central server 12. A data cube class definition may be used to create a data cube for use in generation of the report. A data cube is a multidimensional data structure used to aggregate data from the associated underlying data table(s) and/or data source(s). While the term “cube” is utilized, a data cube may include more than three dimensions. As such, use of the term “cube” does not restrict a data cube to three data dimensions. Rather, a data cube may have dimensions that may correspond to associated fields in a database table of the source of the data (e.g., including any of the fields described above in relation to the dose order data), which may include many more than three dimensions. Dimensions may also be provided with levels, which may be hierarchical (e.g., to provide drilldown functionality in resulting reports based on a data cube). A data cube also may have measures comprising data elements that are values based on underlying data (e.g., that result from application of a function to the data). For example, measures such as an average, a sum, a minimum, a maximum, or other function may be applied to generate a measure included in a data cube. In this regard, the measures may be provided in the underlying data source or may be calculated based on the data in the underlying data source.
A data cube class definition may be developed to develop specific measures, dimensions, levels, values, indices, or other tools used in the data analytics process. Once all of the measures, dimensions, values, indices, etc., are defined for a data cube in the data cube class definition, and then the cube must be compiled. Compilation creates all of the necessary classes required to define and access the data in the form of the data cube. The final step is to build the data cube. The step of building the data cube populates all of the cube dimensions with data so that it can be viewed and reported on. In this regard, a batch job may, on a periodic basis, execute to synchronize the data from the source tables (e.g., the data stored at the central server 12) to the data cube as defined by the data cube class definition.
Once built, the data cube may be static, yet used by a user to generate dynamic reports (e.g., tables, charts, graphs, pivot tables, dashboards, etc.) based on the underlying data cube. The data analytics tool may have various levels of responsibility that may be used to perform various functions relative to the data analytics tools. For instance, a user may be authorized to utilize an architect tool that allows data cube class definitions to be created. Additionally, a user may be authorized to utilize an analyzer tool that allows for creation of reports, pivot tables, or other analysis tools based on a built data cube. Furthermore, a user may be allowed to utilize a viewing tool that displays results from pre-defined reports, pivot tables, dashboards, or other predefined analytics report outputs (e.g., designed by the analyzer tool). An administrator level of access may be provided that facilitates access to all levels, and other specific roles may be developed with privileges related to a plurality, but potentially less than all, responsibility levels of the data analytics tool.
With further reference to
The central server reports page may include a link to an analytics report if the user has sufficient credentials to access the analytics report and/or if the central server reports page is configured for the site from which the user is accessing the central server. Upon the user requesting 408 an analytics report from the central server, the central server may create 410 an authentication token that is in turn stored in a database at the central server. The central server may also invoke 412 a data analytics tool. When the data analytics tools invoke 412, the token that is created 410 may be passed to the data analytics server when the data analytics tool is invoked 412.
In this regard, when the data analytics server receives request to access a data analytics tool provided on the data analytics server, the data analytics server may initiate 414 a cryptographic service provider to perform the delegated authentication of the user requesting access to the data analytics tool. Specifically, the cryptographic service may contact the central server with the information regarding the token that is received from a user access request. If the token matches a token provided in the database at the central server, the user may be authenticated. In turn, the valid token is deleted 418 from the central server to prevent unauthorized future use of that particular token. In this regard, upon a user requesting 408 access to the analytics report from the central server, a token is created 410 and stored at the central server. The user may be redirected to invoke 412 the data analytics tool and the corresponding token created may be provided along with the request. In this regard, when the data analytics server receives a request for authentication, the cryptographic service provider may contact the central server to determine whether the token provided in the request matches one created in the database. In this regard, unauthorized requests for access to the data analytics server using a token that does not have a corresponding token stored in the central server may not be authenticated, thus reducing the ability for the tool to be accessed by unauthorized users with fraudulent or expired tokens. In this regard, the token may be analyzed by the cryptographic service provider to determine 416 if the requested user access is authenticated. In turn, the user may be identified 420 at the data analytics server at least in part based on the authentication from the central server. That is, the login information provided to the local server 402 may be in turn pass to the central server.
Additionally, the central server may provide the user information to the data analytics server 420 to identify the user. This information may comprise a session variable that may, for example, identify the user as described below and/or include information regarding a role and/or resources available to the user based on the user's credentials. This may include defining a user and or facility attempted to access the data analytics server. In turn, based on the user identification, roles and resources may be assigned 422 from the data analytics server to the user attempting to access the data analytics server to invoke a data analytics tool. In this regard, appropriate data cubes may be invoked 424 based on the user identification that are in turn applied to the central server data based on the user identification. As described above, the appropriate data cubes may filter data at the central server such that a user from a given facility may only access the data corresponding to that facility when utilizing the data analytics tool. Furthermore, depending upon the roles and resources assigned at 422, different ones of the data cubes may be provided to the user to run various different reports regarding a data. In turn, an analytics report may be generated 426 based on the plight data cubes and report may presented 428 the user.
Specifically, upon identification of the user requesting access the data analytics tool provided on the data analytics server, the authentication may include logging a user into to a data analytics environment as a data analytics user with the appropriate roles assigned. For instance, during delegated authentication, the requesting user may be logged-in with a user name in the format <customerID>|<userID>|<username>, where <customerid> is the customer ID (e.g., corresponding to a facility) from which the user is accessing the central report pages. For example, the user identification may be provided as part of a session variable communicated to the data analytics server. Rather than the customer ID, a 0 may be used to populate this field for support users accessing the data analytics will from the central server directly, <userID> may be the user ID corresponding to the user (e.g., with 0 being used again for support users accessing the data analytics tool directly from the central server), and the username may be the user's login id. As an example, the Administrator user from customer ID 5, with a central server user id of 10 will be logged in as “5|10|Administrator”.
In turn, when accessing data for generation of reports using the data analytics tool, the user identification (e.g., such as that described above) may be utilized to limit the data to which a data cube class definition is applied or limit the data to which a user may access when generating a report. For instance, in one implementation, a base cube class definition may be provided from which all other data cube class definitions dependent. In this regard, all data cube class definitions may inherit from the base cube class definition. To prevent unauthorized access from the local server, all developed data analytics tool data cube class definitions inherit from the base cube class definition that comprises a special security filter class definition. In this regard, the base queue class definition may include an organization identifier and a customer identifier as default dimensions, in addition to any other dimensions to be included in the cube definition. The base cube class definition may use these two properties to include only records from the specific customer or organization account based upon the received user identification information during the user authentication process. This acts as a security mechanism to prevent users from accessing other customer data on the central server.
For instance, to filter central server data based on a user's access to organization or site data, the base cube detects whether the user is an organization level user or a site level user. Based on the evaluation, a multidimensional expression filter string is assembled based on either the organization or sites that the user belongs to. Once the filter string is assembled, the multidimensional expression filter is applied to all data in the base cube (e.g., which must include dimensions corresponding to the organization ID or client ID) and limits the information that the user sees in any report. As such, the base cube class definition may, in conjunction with the user identification information received during the authentication process, serve to limit access for a user to data only corresponding to the facility (or organization) to which the user belongs or from which the user is accessing the tool. As such, while the data analytics tool operates on aggregated data corresponding to a plurality of facilities, the base cube class definition from which all other data cube class definitions depend, may serve to limit access to data correspond to the user's facility. Because internal users (e.g., users accessing the data analytics tool from the central server directly) must also be able to access the data from the data analytics tool, the base cube class definition also detects whether or not the user has accessed the environment from the local server or directly using the central server. It may accomplish this by determining if the session variables for a given user session in which a user requests access to the data analytics tool is populated with the expected parameters. If so, then access is assumed to by via the local server. If not, then access is assumed to by via the central server screens and a check is made of the roles attributed to the user session definition to see if the correct roles are assigned to the user accessing the data analytics tool from the central server.
Additionally, a protected heath information (PHI) parameter may be used to indicate if PHI information is exposed by the cube. This will allow reports to be generated to identify cubes with PHI information. Cubes containing PHI information may also require a specific resource attributable to specific users to access the cube. This will limit access to pivot tables and dashboards derived from those cubes containing PHI. In this regard, a particular concern regarding exchange of medical information includes maintaining the privacy of patients as it relates to the exchange of medical information. For instance, medical information may include patient identifying information (e.g., potentially including PHI). In this regard, dissemination of medical information may subject to restrictions due to regulatory issues (e.g., the Health Insurance Portability and Accountability Act (HIPAA) in the United States) may prohibit dissemination of medical information with PHI or other privacy concerns. While HIPAA may define PHI, it may be appreciated that as used herein PHI may include data included in the HIPAA definition as well as other data. For instance, any patient identifying information (e.g., patient name, patient identification number, etc.) may be defined as PHI.
Furthermore, data cube class definitions may include data transformations that are applied to data from the data source. These transformations may include generating calculated measures based on underlying source data. The transformations may also include modification to the source data. For example, in one specific example related to total parenteral nutrition (TPN) doses, certain dose order record fields may be acted upon by a corresponding data cube class definition. In this regard, a data cube class definition, during the build process, may replace a given dose order field (e.g., a DoseDescription field) with the value from another field (e.g., the DoseDrugNames field). This transformation may be applied only to a certain type of doses (e.g., for TPN doses as determined by a record flag indicating whether the dose order is a TPN order or based on a drug contained in the order). As such, during cube building, a record from the source data table will be determined if the record contains the appropriate fields (e.g., “DoseDescription”, “TPN”, and “DoseDrugNames” following the example above). Once a record is determined to be a TPN order to which the data transformation applies, the data analytics server will check the TPN field and if it is set to 1 (the dose is TPN) then the value of field “DoseDrugNames” may be copied into the field “DoseDescription”.
Additionally, each data cube class definition is such that when building the data, the cube will not load any records from sites designated with the “Data Exclusion” flag. In this regard, the base cube class definition may determine if a record is for a customer site with the data exclusion designation and if so, it will skip the record from being loaded. The data exclusion designation 522 is set in the server detail page 520 shown in
In this regard and with further reference to
With returned reference to data cube class definitions, certain useful data transformation techniques may be provided for use with a data cube class definition. For instance, a protected health information (PHI) parameter may be provided (e.g., with all cubes) to identify if the cube exposes PHI information. If a parameter indicative of PHI being present is determined to be true, then the cube contains PHI fields, otherwise the cube is not considered to contain PHI fields. The PHI parameter may be dynamically generated based on the underlying data source to which the cube class definition is applied (e.g., whether any source data is determined to have PHI).
Additionally, a delta time function may be provided. The delta time function may be used to calculate the time difference between two times. Each time value may be passed as a parameter to the function and the time difference (e.g., as measured in minutes, hours, days, seconds, etc.) is returned as the value of the dimension. As such, when a cube measure is created that will use the time function, a measure name may also created that is representative of the time measure being extracted. For instance, a measure called “DeliveredTimeMinutes” could be defined as the difference between the time the dose was delivered to the patient and the time it was received in the pharmacy. Continuing the example, the data cube class definition having the cube measure “DeliveredTimeMinutes” may have instructions such that a specific method call performs the actual calculation and the source data elements are the time values to be compared. For instance, the specific method call may return the difference of the defined time measures to be compared and return the value as a positive integer.
Furthermore, one or more custom time functions may be created. Custom functions can be created to evaluate any number of desired results. For a custom time reporting function that relies on multiple inputs to evaluate an elapsed time, a custom time function that may take four time inputs and evaluates the dose preparation time based on coded criteria using the four input values may be provided. This method may take the four defined time value and perform specific calculations thereto (e.g., evaluating the time doses were at various stages of processing defined by the four inputs).
Additionally, record filtering may be provided by a data cube class definition. This may allow for record filtering to eliminate records from the cube dataset that are not needed. This may be thought of as similar to adding a WHERE clause to and SQL statement. In this regard, by setting up an “if” statement to determine if a record should be included or not records can be excluded from the fact table when building the cube. For instance, in an example a data cube class definition may filter records based on the contents of one or more given dimensions in the cube (e.g., Type and ErrorCategory).
Additionally, the cube definition may include the listing tag which defines the fields to display to the users when they drill-down within a pivot table or dashboard. A pivot table may have multiple listings defined. When defining a pivot table based on a cube, the pivot table designer may select which listing to display when the end-user drills down on the pivot table. The dashboards based on that pivot table may also inherit the ability to drill down in the data to display the listing specified during the pivot table design.
Furthermore, a data cube class definition may include an operation that is utilized to de-identify patient information contained within the data for a given data cube. For example, a hash function or the like may be applied to the patient information, thereby rendering the resulting data in the data cube non-identifying of the patient. In further embodiments, the source data for a data cube class definition may be a data source in which the patient identifying information has been removed (e.g. by a hash function or the like).
Additionally, upon a user accessing the data analytics tool, a log event may be created that provide logging information with respect to the user accessing the data analytics tool and various specific resources accessed during a session. In this regard, log entries for a given user session and/or navigation occurring within the user session may be generated (e.g., by a logging module at the central server 12 and/or data analytics server 16). These log sessions may provide access regarding a particular session to achieve user is defined and may provide details regarding specific navigation of the user during the session. In turn, the user logs may be reviewed to determine which users access is accessed which resources and particular parameters in connection with that access. In connection therewith, a schema 600 corresponding to an embodiment of a user log is depicted in
Accordingly, with further reference to
Additionally, for each session log, sub-records comprising a central navigation log 620 corresponding to session activity or navigation may be created. The central navigation log 620 may include properties such as, for example, the property “Central User Session” that links to the central user session log 610 associated with the navigation being logged. The log 620 may also include the property “Class Relative URL” corresponding to the class accessed. The property “Contains Patient Information” may be a true/false indication as to whether the resource (e.g., page, report, tool) being accessed contains PHI information. In this regard, either the a parameter “HASPHI” may be set to 1, or the report definition field “ContainsPHI” may be set to 1 if a report is being executed that includes PHI. The log 620 may also include the property “Customer” that indicates 1 the customer from which the user is accessing the tool. The property “Data Analytics Access” may indicate the resources from the data analytics tool utilized (e.g., including the data cube definitions invoked or the like). The property “Entry Date” may correspond to the date the session was entered, and the property “Entry Date Time” may correspond to the date/time the session was entered. The log 620 may also include the property “Report” that indicates the identity of a report accessed, if any. The property “Report Exported” may include an indicator as to whether the report was exported. The property “Report Parameters” may include the parameters selected by the user when running a report or otherwise utilizing the data analytics tool. The property “Report Query” may include an identity of the query executed to generate a report, and “Report Record Count” may include the record returned by the report. The property “Server Process Time” may correspond to the processing time in ms (milliseconds). The property “Source” may include an indication of the customer source if the user was redirected from a local server.
In relation to the foregoing description, it may be appreciated that the data analytics tool described herein may be utilized in a number of different contexts in relation to dose order data. Thus, while dose order data is referenced throughout the present disclosure, such data may include and/or provide for far reaching data analytics. For instance, as described above the dose order data upon which the data analytics tool may be invoked may include a plurality of different dose order data classes that may include information related to the dose order, the preparation of the dose order, products used during the preparation of the dose order, or any other related information. In this regard, it may be appreciated that a plurality of different categories of data cube class definitions may be provided in a data analytics tool. Importantly, all such data cube class definitions may depend from the base cube class definition that permits selective, secure access to the facility (or organization) specific data corresponding to a given user.
For instance, a number of categories of data cube class definitions may be provided. For example, the data cube class definitions may relate to, as way of example, general pharmacy workflow activity, pharmacy performance metrics, pharmacy exceptions, pharmacy usage and waste, data related to products and therapies, compliance data, and user logs. In this regard, examples of data cube class definitions in the general pharmacy workflow activity category may include a data cube class definition corresponding to basic statistics regarding dose orders, dose order items, dose preparation information, dose claim activities, dose scan events, dose verification history, and procedure summaries. In this regard, the data cube class definition corresponding to basic dose statistics may include dose dimensions related to, for example, dose administration time, whether the dose was a first dose in a series of doses, the dose route (e.g., intravenous, oral, intramuscular, etc.), whether the dose a hazmat dose, whether the dose is a high-risk doses, the nursing unit corresponding to the dose, whether the dose is a STAT dose, whether the dose is a total parenteral nutrition (TPN) dose, the type of TPN dose, whether the dose includes an unknown drug, the technician that prepared the dose, the workstation that was used to prepare the dose, whether the dose is a stock dose, whether the dose is a dilution dose, the dose status, the dose preparation date, the dose entry hour, and the dose entry minute. Furthermore, any of the foregoing dimensions may include normalized versions of the dimensions (e.g. for instance in the case of normalized drug names, normalized amounts, normalized units, or the like). Furthermore, some data cube class definitions that provide dose order summary data may include measures related to the total volume of the dose, the final volume of the dose, a QS volume of the dose, a QS diluent name, a stock dose count, a dilution dose count, a number of rework doses, in-line verification of a dose, the number of images per prepared dose, the number of fully compounded doses by a compounder, the number of dose manual additions, the number of doses with material requests, the number of doses having expanded drug names, the number of doses by status, the number doses by route, the number of attachments for a dose order record, and a normalized dose description. For data cube class definitions regarding dose order items, the data cube class definitions may relate to dimensions corresponding to the dose status (e.g., to filter our records that have not actually been delivered to a patient), a dose description, a dose description normalized based on formulary drug names, base units, and diluents, whether the dose is a stock dose, whether the dose is a dilution dose, whether the dose is a hazmat dose, whether the dose is a high risk dose, the total volume of the dose (e.g., including contributions small products), the final volume of the dose (e.g., as specified for the dose order by an electronic medical record (EMR) system or hospital information system (HIS)), the QS volume, and a QS diluent name. Data cube class definitions related to the dose preparation information may include data dimensions corresponding to the preparation mode used to prepare a dose, preparation mode options the time the dose was prepared, and a calculated QS volume for a dose. Data cube class definitions may relate to the occurrence of a pharmacist claiming a dose during verification (e.g., from another use who has a session verifying the dose). In this regard, dose claim data cube class definitions may include data dimensions corresponding to whether a dose was claimed during verification, whether the individual claiming the dose disposed of the dose that was claimed, the reason a claim was successful or unsuccessful, whether the claim was overwriting another user's claim, the time a claim is active, the overwriting user, the overridden user, and a dose identifier. Data cube class definitions related to dose scan events may include data dimensions related to the scan event name, the dose order identifier, the product lot identifier, a catalog identifier, a user identifier for the scan, and the event target (e.g., calculated to determine the dose order, product blog, or kit event type). Data cube class definitions related to dose verification history may include data dimensions corresponding to the user identifier of the user who verifies the dose, the date/time the dose is verified, the results of the verification, the reason provided during verification (e.g., for requeue, cancellation, and rework orders), the dose identifier, the verification type, the disposition of the dose, a reason for remake, and a rejected product log. Data cube class definitions related to procedure records may include the entry date and time of the dose, the completed date and time of the dose, the user identifier of the technician used to prepare the dose, the workstation identifier of the workstation used to prepare the dose, the name of the dose, a central formulary procedure ID (e.g., corresponding to a procedure presented the user in the preparation), a procedure type, a completed action count, a required action count, a total action count, and a completion time.
Additionally, a number of performance data cube class definitions may be provided that may include information regarding dose turnaround time and system performance. For data cube class definitions regarding dose turnaround time, the data cube may include dimensions related to a workstation used to prepare the dose, a preparation location name, a technician name, a patient location, a nursing unit corresponding to the dose, a priority of the dose, whether the dose is a STAT dose, whether the dose is a hazmat dose, a number of items in the dose, whether the dose is a stock order, dose drug names, and a preparation date/time. Furthermore, a number of measures may provided for a data cube class definition related to the dose turnaround time including an average time preparation, a delivered time, a waiting for preparation time, a time to resume preparation after an in-line verification or rework, a time until dose distribution, a average time to verify the dose, and an average time to sort the dose. The data cube class definition regarding system performance may include data dimensions corresponding to the time/date of a log, the calculated record length of the session, a function name, an average data analytics server execution time, and average client server execution time, a maximum data analytics server execution time, a maximum client server execution time, a minimum data analytics server execution time, a minimum client server execution time, and an execution count.
Furthermore, a number of data cube class definitions related to dose exceptions may be provided. Examples may include data cube class definitions related to prevented error (e.g., scan errors), detected errors, bypass reasons, dose order modifications, and alerts. Accordingly, prevented errors may correspond to errors identified by the pharmacy workflow management application automatically without human intervention (e.g., scan errors or the like) and the detected errors may include errors identified by a human interacting with the pharmacy workflow management application such as a pharmacist during a dose review. A data cube class definition related to scan errors may include data dimensions related to doses containing a prevented error generated during dose preparation, a dose category, a dose identifier, a scanned barcode, a scan formulary product information, scan product log information, technician information, and workstation information. The data cube class definition related detected errors may include detected error data generated at the pharmacist check station. Data dimensions contained within the detected errors data cube class definition may include a reason for remaking a dose, pharmacist information, technician information, workstation information, preparation location, a nursing unit associated with the dose, a dose route for the dose, whether the dose is a hazmat dose, a type of hazmat dose, whether the dose is a TPN order, a the dose description. A data cube class definition related to bypass reasons may include information related to doses in connection with a bypass print operation whereby the dose order, upon being received by the pharmacy workflow management application, is bypassed for printing of the dose order by a label printer in a traditional fashion. As such, data dimension for the bypass reasons data cube class definition may include an indication that the dose was bypassed, a time and date of the order entry, drug information corresponding to the dose order, information regarding the source of the data order, etc. A data queue class definition regarding dose order modifications may include data dimensions including what modification was made to the dose including an administration date/time update, a discontinuation of a dose, a change in priority for dose, a movement of the dose onto or off of a hold status, an expiration date/time of a dose due to using a stock product with an earlier expiration date, whether an adjustment was done automatically by the system or intentionally by user, who made a modification, and why a modification was necessary (e.g., if the site is configured to enter reason for modification). A data cube class definition related to dose alerts may include data dimensions corresponding to whether a dose is subject to an alert during the preparation process and other dose identifying information that may allow trends with relation to a dose alert to be determined Other data cube class definitions may include data dimensions regarding received alerts (e.g., from within a pharmacy workflow management system or from an external alert provider) regarding dose orders, patients, drugs, or some other portion of data stored by a pharmacy workflow management application.
Data cube class definitions may also relate to usage and waste metrics in the pharmacy. Examples may include data cube class definitions related to product waste, drug waste, and products siblings. Accordingly, a product waste data cube class definition may include data dimensions corresponding to data from unused/expired products such as product preparation location, preparing technician information, dose status, dose name, an NDC code for drugs in the dose, a total volume of the dose, a current volume of the dose, an expiration date of the dose, a number of prepared doses, an unused volume ratio (i.e., the current volume divided by the total volume), a cost for the dose (e.g., referenced from a formulary record for a drug or product associated with the dose), and whether the dose was a multi-use dose. For instance, a resulting report based on the product waste data cube generated from the product waste class definition may include an aggregate of an amount of drug wasted over a given time period and/or the cost associated with that corresponding waste (e.g., using underlying data and/or measures defined in the data cube class definition). A drug waste data cube class definition may include data dimensions corresponding to a product log identifier, an entry date, an expiration date, an activation date, a number of beyond use hours for the dose, a drug name, an amount of the dose, units of the dose, whether the dose is a hazmat dose, whether the dose is a high risk dose, and whether the dose of the diluent dose. In this regard, the beyond use hours data dimension may be a calculated measure that includes the difference between the expiration date and activation date and hours.
The product and therapy category of the data cube class definitions may include data cube class definitions related to therapy summaries and drug combinations. Accordingly, a data queue class definition related to therapy summaries may include data dimensions corresponding to the ability to see a drug therapy instance in terms of average duration (e.g., a number of days, number of doses, or total dose amounts) including, for example, a customer identifier, a source identifier, an entry date for the dose, drug names for the dose, a dose description, and a therapy ID. The drug combination data cube class definition may include a “cross-tab” showing the frequency of a combination of drugs when given together. Data dimensions for this data cube class definition may include a customer identifier, a source identifier, an entry date for the dose, a drug name associated with the dose, an amount of the dose, a unit of the dose, and a dose identifier.
A number of data cube class definitions may be related to compliance tracking. Examples may include data cube class definitions related to schedule task histories and weight measurements. The schedule task histories data cube class definition may include data dimensions that may allow for compliance tracking with scheduled tasks to be completed in relation to workstations. In this regard, the data dimensions for the data cube may include workstation tasks, a missed task dose count (e.g., including the number of bad doses because a clean task is not completed on time), information on completed tasks (e.g., including the user, time, workstation, whether the task was overdue, and an overdue time), how many doses were prepared on an overdue workstation by user, a frequency type, a frequency value, a previous completion date/time, a previous due date time, and next due date time. A weight measurement data cube class definition may include data corresponding to weight measurements recorded dose preparation workstation. Furthermore, data queue class definitions related to compliance tracking may allow for filtering and/or searching of doses based on a number of different data dimensions such as, for example, dose type, dose preparation date, technician, location, or any other appropriate dimension. Furthermore, the dynamic report generated based on the compliance tracking may allow for a user to drill down through various dimension levels. At a given level, user may select to view individual dose order records comprising a given set of data (e.g., a chart cell or graph portion may correspond to a certain number of doses, which may be revealed as a listing of the specific dose order records referenced by the chart cell a graph portion upon selection by the user). That is, the report may allow a user to define or select various parameters that allow a user to access a list of doses that meet a criteria established by the user using the selection of various parameters. The compliance tracking data cube may include a link that allows a user to retrieve a dose order log corresponding to a given dose order contained in the listing of specific dose order records. The dose order log may include any or all information related to the selected dose order (e.g., including data regarding the dose order record outside of the data dimensions of the data cube used to filter or search for the dose order itself). That is, the dose order log may include any or all information regarding the dose order log even if that dose order information does not comprise a dimension contained in the data cube used to obtain the link to access the dose order log for the dose order record. In an application, the dose order log linked to in the compliance tracking data cube may correspond to a dose order log with a specific format and/or data content dictated by an authority such as a government regulatory body or the like for use in determining regulatory compliance.
Additionally, a number of data cube class definitions may be related to user logs. Examples may include data related web sessions, data related to workstation sessions, data related to central user sessions, and data related to central user navigation, and audit logs. A data queue class definition for web sessions information may include data dimensions corresponding to information relevant to web-based user sessions including, for example, an IP address of the user, a login date/time, a logout date/time, a browser name, a browser version, a browser extension installation version, a length of the session, a indication of the breakdown between site configuration time and dose preparation functionality time, an average response time from the server for web service calls, and an average response time for webpage requests. The data cube class definition related to workstation sessions may include data dimensions related to a login date/time for workstation, a logout date/time for the workstation, a workstation software version, the workstation name, a work station location, a username accessing the workstation, and a last activity date/time. A data cube class definition related to central user sessions may include data dimensions corresponding to a central session log, a total session time, and a browser type/version. A queue class definitions related to central user navigation may be based on a central navigation log. An audit log data class definition may be operative to compare a full snapshot of audit logs and identify which fields have changed.
Other data cube class definitions may be provided without limitation that may leverage various ones of the data dimensions present in dose order information. Furthermore, the source data to which data cube class definitions may extend beyond dose order data. For instance, additional data sources (e.g., located at hospital information systems, pharmacy information systems, laboratories, surgical data repositories, formulary records, national healthcare databases, etc.) may be accessible by the data analytics tool. In this regard, data cube class definitions that reference such data sources may be provided. Additionally, data cube class definitions may be provided for use in building data cubes that reference multiple data sources (e.g., including dose order data as well as other data sources such as those listed above including hospital information systems, pharmacy information systems, laboratories, surgical data repositories, and national healthcare databases). In any regard, the foregoing data cube class definitions may be utilized in building corresponding data cubes. In this regard, one or more reports may be generated that reference a data cube for presentation of data to a user. The reports may take the form of pivot tables, dashboards, charts, graphs, or other report mechanisms. The reports may be filterable based on various different data dimensions such as, for example, dose order types, dates, dose statuses, technician, pharmacist, or any other data dimension included in the data cube and defined relative to the report (e.g., which may be modifiable by a user with appropriate role or responsibility). Furthermore, the reports may include drill downs based on the dimension levels as discussed above to provide increasingly detailed data based on a subset of data for a given dimension. In this regard, a user may be able to utilize the reports to identify trends, anomalies, patterns, or other information from the data presented in the dynamic report generated based on a data cube.
While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description is to be considered as exemplary and not restrictive in character. For example, certain embodiments described hereinabove may be combinable with other described embodiments and/or arranged in other ways (e.g., process elements may be performed in other sequences). Accordingly, it should be understood that only the preferred embodiment and variants thereof have been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
This application claims priority from U.S. Provisional Application No. 62/088,358 filed on Dec. 5 2014 entitled “DOSE PREPARATION DATA ANALYTICS,” the contents of which are incorporated by reference herein as if set forth in full.
Number | Name | Date | Kind |
---|---|---|---|
641748 | Smith | Jan 1900 | A |
819339 | Cleland | May 1906 | A |
3426150 | Tygart | Feb 1969 | A |
3739943 | Williamsen et al. | Jun 1973 | A |
3742938 | Stern | Jul 1973 | A |
3756752 | Stenner | Sep 1973 | A |
3774762 | Lichtenstein | Nov 1973 | A |
3786190 | Pori | Jan 1974 | A |
3809871 | Howard et al. | May 1974 | A |
3810102 | Parks, III et al. | May 1974 | A |
3848112 | Weichselbaum et al. | Nov 1974 | A |
3858574 | Page | Jan 1975 | A |
3878967 | Joslin et al. | Apr 1975 | A |
3910257 | Fletcher et al. | Oct 1975 | A |
3910260 | Sarnoff et al. | Oct 1975 | A |
3921196 | Patterson | Nov 1975 | A |
3971000 | Cromwell | Jul 1976 | A |
3995630 | Verrdonk | Dec 1976 | A |
3998103 | Bjorklund et al. | Dec 1976 | A |
4032908 | Rice et al. | Jun 1977 | A |
4078562 | Friedman | Mar 1978 | A |
4144496 | Cunningham et al. | Mar 1979 | A |
4151407 | McBride et al. | Apr 1979 | A |
4156867 | Bench et al. | May 1979 | A |
4164320 | Irazoqui et al. | Aug 1979 | A |
4173971 | Karz | Nov 1979 | A |
4199307 | Jassawalla | Apr 1980 | A |
4270532 | Franetzki et al. | Jun 1981 | A |
4273121 | Jassawalla | Jun 1981 | A |
4282872 | Franetzki et al. | Aug 1981 | A |
4308866 | Jelliffe et al. | Jan 1982 | A |
4319338 | Grudowski et al. | Mar 1982 | A |
4320757 | Whitney et al. | Mar 1982 | A |
4354252 | Lamb et al. | Oct 1982 | A |
4369780 | Sakai | Jan 1983 | A |
4370983 | Lichtenstein | Feb 1983 | A |
4373527 | Fischell | Feb 1983 | A |
4381776 | Latham, Jr. | May 1983 | A |
4385630 | Gilcher et al. | May 1983 | A |
4398289 | Schoate | Aug 1983 | A |
4398908 | Siposs | Aug 1983 | A |
4414566 | Peyton et al. | Nov 1983 | A |
4416654 | Schoendorfer et al. | Nov 1983 | A |
4425114 | Schoendorfer et al. | Jan 1984 | A |
4428381 | Hepp | Jan 1984 | A |
4443216 | Chappell | Apr 1984 | A |
4447224 | Decant, Jr. et al. | May 1984 | A |
4449538 | Corbitt et al. | May 1984 | A |
4451255 | Bujan et al. | May 1984 | A |
4457750 | Hill | Jul 1984 | A |
4458693 | Badzinski et al. | Jul 1984 | A |
4460358 | Somerville et al. | Jul 1984 | A |
4464172 | Lichtenstein | Aug 1984 | A |
4469481 | Kobayashi | Sep 1984 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
4476381 | Rubin | Oct 1984 | A |
4480751 | Lueptow | Nov 1984 | A |
4481670 | Freeburg | Nov 1984 | A |
4487604 | Iwatschenko et al. | Dec 1984 | A |
4490798 | Franks et al. | Dec 1984 | A |
4496351 | Hillel et al. | Jan 1985 | A |
4511352 | Theeuwes et al. | Apr 1985 | A |
4525861 | Freeburg | Jun 1985 | A |
4526574 | Pekkarinen | Jul 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4531527 | Reinhold, Jr. et al. | Jul 1985 | A |
4538138 | Harvey et al. | Aug 1985 | A |
4545071 | Freeburg | Oct 1985 | A |
4551133 | Zegers de Beyl et al. | Nov 1985 | A |
4559038 | Berg et al. | Dec 1985 | A |
4560979 | Rosskopf | Dec 1985 | A |
4561443 | Hogrefe et al. | Dec 1985 | A |
4562751 | Nason | Jan 1986 | A |
4564054 | Gustaysson | Jan 1986 | A |
4590473 | Burke et al. | May 1986 | A |
4602249 | Abbott | Jul 1986 | A |
4619653 | Fischell | Oct 1986 | A |
4622979 | Katchis et al. | Nov 1986 | A |
4624661 | Arimond | Nov 1986 | A |
4636950 | Caswell et al. | Jan 1987 | A |
4637817 | Archibald et al. | Jan 1987 | A |
4650469 | Berg et al. | Mar 1987 | A |
4652262 | Veracchi | Mar 1987 | A |
4653010 | Figler et al. | Mar 1987 | A |
4676776 | Howson | Jun 1987 | A |
4681563 | Deckert et al. | Jul 1987 | A |
4688167 | Agarwal | Aug 1987 | A |
4691580 | Fosslien | Sep 1987 | A |
4695954 | Rose et al. | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4697928 | Csongor | Oct 1987 | A |
4702595 | Mutschler et al. | Oct 1987 | A |
4705506 | Archibald | Nov 1987 | A |
D293135 | Medema et al. | Dec 1987 | S |
4714462 | DiComenico | Dec 1987 | A |
4717042 | McLaughlin | Jan 1988 | A |
4718576 | Tamura et al. | Jan 1988 | A |
4722224 | Scheller et al. | Feb 1988 | A |
4722349 | Baumberg | Feb 1988 | A |
4722734 | Kolln | Feb 1988 | A |
4730849 | Siegel | Mar 1988 | A |
4731058 | Doan | Mar 1988 | A |
4732411 | Siegel | Mar 1988 | A |
4741732 | Crankshaw et al. | May 1988 | A |
4741736 | Brown | May 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4759756 | Forman | Jul 1988 | A |
4770184 | Greene et al. | Sep 1988 | A |
4778449 | Weber et al. | Oct 1988 | A |
4779626 | Peel et al. | Oct 1988 | A |
4784645 | Fischell | Nov 1988 | A |
4785799 | Schoon et al. | Nov 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4796644 | Polaschegg | Jan 1989 | A |
4797840 | Fraden | Jan 1989 | A |
4803625 | Fu et al. | Feb 1989 | A |
4810090 | Boucher | Mar 1989 | A |
4810243 | Howson | Mar 1989 | A |
4811844 | Moulding, Jr. et al. | Mar 1989 | A |
4816208 | Woods et al. | Mar 1989 | A |
4817044 | Ogren | Mar 1989 | A |
4828545 | Epstein et al. | May 1989 | A |
4829524 | Yoshida | May 1989 | A |
4830018 | Treach | May 1989 | A |
4831562 | Mcintosh et al. | May 1989 | A |
4832033 | Maher et al. | May 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4835521 | Andrejasich et al. | May 1989 | A |
4838275 | Lee | Jun 1989 | A |
4839806 | Goldfischer et al. | Jun 1989 | A |
4845644 | Anthias et al. | Jul 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4850009 | Zook et al. | Jul 1989 | A |
4850972 | Schulman et al. | Jul 1989 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4854324 | Hirschman et al. | Aug 1989 | A |
4857713 | Brown | Aug 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
4865584 | Epstein et al. | Sep 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4878175 | Norden-Paul et al. | Oct 1989 | A |
4880013 | Chio | Nov 1989 | A |
4889132 | Hutcheson et al. | Dec 1989 | A |
4889134 | Greenwold et al. | Dec 1989 | A |
4893270 | Beck et al. | Jan 1990 | A |
4897777 | Janke et al. | Jan 1990 | A |
4898209 | Zbed | Feb 1990 | A |
4898576 | Philip | Feb 1990 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4901728 | Hutchison | Feb 1990 | A |
4905163 | Garber et al. | Feb 1990 | A |
4908017 | Howson et al. | Mar 1990 | A |
4912623 | Rantala et al. | Mar 1990 | A |
4916441 | Gombrich et al. | Apr 1990 | A |
4922922 | Pollock et al. | May 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4933843 | Scheller et al. | Jun 1990 | A |
4937777 | Flood et al. | Jun 1990 | A |
4941808 | Qureshi et al. | Jul 1990 | A |
4943279 | Samiotes et al. | Jul 1990 | A |
4943987 | Asahina et al. | Jul 1990 | A |
4946445 | Lynn | Aug 1990 | A |
4949274 | Hollander et al. | Aug 1990 | A |
4952928 | Carroll et al. | Aug 1990 | A |
4953074 | Kametani et al. | Aug 1990 | A |
4960230 | Marelli | Oct 1990 | A |
4964847 | Prince | Oct 1990 | A |
4966579 | Polaschegg | Oct 1990 | A |
4967928 | Carter | Nov 1990 | A |
4968295 | Neumann | Nov 1990 | A |
4975647 | Downer et al. | Dec 1990 | A |
4977590 | Milovancevic | Dec 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
4991091 | Allen | Feb 1991 | A |
4992926 | Janke et al. | Feb 1991 | A |
4993068 | Piosenka et al. | Feb 1991 | A |
4993506 | Angel | Feb 1991 | A |
4998249 | Bennett et al. | Mar 1991 | A |
5002055 | Merki et al. | Mar 1991 | A |
5003296 | Lee | Mar 1991 | A |
5006699 | Felkner et al. | Apr 1991 | A |
5007429 | Treatch et al. | Apr 1991 | A |
5012402 | Akiyama | Apr 1991 | A |
5012411 | Policastro et al. | Apr 1991 | A |
5014875 | McLaughlin et al. | May 1991 | A |
5016172 | Dessertine | May 1991 | A |
5023770 | Siverling | Jun 1991 | A |
5025374 | Roizen et al. | Jun 1991 | A |
5036852 | Leishman | Aug 1991 | A |
5038800 | Oba | Aug 1991 | A |
5041086 | Koenig et al. | Aug 1991 | A |
5045048 | Kaleskas et al. | Sep 1991 | A |
5047959 | Phillips et al. | Sep 1991 | A |
5053031 | Borsanyi | Oct 1991 | A |
5053990 | Kreifels et al. | Oct 1991 | A |
5055001 | Natwick et al. | Oct 1991 | A |
5057076 | Polaschegg | Oct 1991 | A |
5061243 | Winchell et al. | Oct 1991 | A |
5072356 | Watt et al. | Dec 1991 | A |
5072383 | Brimm et al. | Dec 1991 | A |
5072412 | Henderson, Jr. et al. | Dec 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5084828 | Kaufman et al. | Jan 1992 | A |
5087245 | Doan | Feb 1992 | A |
5088904 | Okada | Feb 1992 | A |
5088981 | Howson et al. | Feb 1992 | A |
5088990 | Hivale et al. | Feb 1992 | A |
5096385 | Georgi et al. | Mar 1992 | A |
5098377 | Borsanyi et al. | Mar 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5100394 | Dudar et al. | Mar 1992 | A |
5103211 | Daoud et al. | Apr 1992 | A |
5104374 | Bishko et al. | Apr 1992 | A |
5108131 | Nassim | Apr 1992 | A |
5108363 | Tuttle et al. | Apr 1992 | A |
5108367 | Epstein et al. | Apr 1992 | A |
5108372 | Swenson | Apr 1992 | A |
5109487 | Ohgomori et al. | Apr 1992 | A |
5109849 | Goodman et al. | May 1992 | A |
5112319 | Lai | May 1992 | A |
5116203 | Natwick et al. | May 1992 | A |
5116312 | Blankenship et al. | May 1992 | A |
5131092 | Sackmann et al. | Jul 1992 | A |
5134574 | Beaverstock et al. | Jul 1992 | A |
5135500 | Zdeb | Aug 1992 | A |
5137023 | Mendelson et al. | Aug 1992 | A |
5151978 | Bronikowski et al. | Sep 1992 | A |
5152296 | Simons | Oct 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5155693 | Altmayer et al. | Oct 1992 | A |
5157595 | Lovrenich | Oct 1992 | A |
5158091 | Butterfield et al. | Oct 1992 | A |
5159673 | Sackmann et al. | Oct 1992 | A |
5160320 | Yum et al. | Nov 1992 | A |
5161211 | Taguchi et al. | Nov 1992 | A |
5167235 | Seacord et al. | Dec 1992 | A |
5169642 | Brinker et al. | Dec 1992 | A |
5172698 | Stanko | Dec 1992 | A |
5176004 | Gaudet | Jan 1993 | A |
5179569 | Sawyer | Jan 1993 | A |
5179700 | Aihara et al. | Jan 1993 | A |
5181910 | Scanlon | Jan 1993 | A |
5190185 | Blechl | Mar 1993 | A |
5190522 | Wojcicki et al. | Mar 1993 | A |
5191891 | Righter | Mar 1993 | A |
5208762 | Charhut et al. | May 1993 | A |
5208907 | Shelton et al. | May 1993 | A |
5211849 | Kitaevich et al. | May 1993 | A |
5213099 | Tripp, Jr. | May 1993 | A |
5213232 | Kraft et al. | May 1993 | A |
5213568 | Lattin et al. | May 1993 | A |
5219330 | Bollish et al. | Jun 1993 | A |
5219331 | Vanderveen | Jun 1993 | A |
5225974 | Mathews et al. | Jul 1993 | A |
5226425 | Righter | Jul 1993 | A |
5228450 | Sellers | Jul 1993 | A |
5231990 | Gauglitz | Aug 1993 | A |
5234404 | Tuttle et al. | Aug 1993 | A |
5235510 | Yamada et al. | Aug 1993 | A |
5236416 | McDaniel et al. | Aug 1993 | A |
5238001 | Gallant et al. | Aug 1993 | A |
5240007 | Pytel et al. | Aug 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5245704 | Weber et al. | Sep 1993 | A |
5254096 | Rondelet et al. | Oct 1993 | A |
5256156 | Kern et al. | Oct 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5261884 | Stern et al. | Nov 1993 | A |
5262943 | Thibado et al. | Nov 1993 | A |
5265010 | Evans-Paganelli et al. | Nov 1993 | A |
5265431 | Gaudet et al. | Nov 1993 | A |
5267174 | Kaufman et al. | Nov 1993 | A |
5271405 | Boyer et al. | Dec 1993 | A |
5272318 | Gorman | Dec 1993 | A |
5272321 | Otsuka et al. | Dec 1993 | A |
5273517 | Barone et al. | Dec 1993 | A |
5277188 | Selker | Jan 1994 | A |
5283861 | Dangler et al. | Feb 1994 | A |
5284150 | Butterfield et al. | Feb 1994 | A |
5286252 | Tuttle et al. | Feb 1994 | A |
5292029 | Pearson | Mar 1994 | A |
5297257 | Struger et al. | Mar 1994 | A |
5298021 | Sherer | Mar 1994 | A |
5304126 | Epstein et al. | Apr 1994 | A |
5307263 | Brown | Apr 1994 | A |
5307372 | Sawyer et al. | Apr 1994 | A |
5307463 | Hyatt et al. | Apr 1994 | A |
5311908 | Barone et al. | May 1994 | A |
5314243 | McDonald et al. | May 1994 | A |
5315505 | Pratt et al. | May 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
5319363 | Welch et al. | Jun 1994 | A |
5319543 | Wilhelm | Jun 1994 | A |
5321618 | Gessman | Jun 1994 | A |
5321829 | Zifferer | Jun 1994 | A |
5324422 | Colleran et al. | Jun 1994 | A |
5325478 | Shelton et al. | Jun 1994 | A |
5327341 | Whalen et al. | Jul 1994 | A |
5331549 | Crawford, Jr. | Jul 1994 | A |
5336245 | Adams et al. | Aug 1994 | A |
5337230 | Baumgartner et al. | Aug 1994 | A |
5337747 | Neftel | Aug 1994 | A |
5337919 | Spaulding et al. | Aug 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5339421 | Housel, III | Aug 1994 | A |
5339821 | Fujimoto | Aug 1994 | A |
5341291 | Roizen et al. | Aug 1994 | A |
5341412 | Ramot et al. | Aug 1994 | A |
5348008 | Bornn et al. | Sep 1994 | A |
5348539 | Herskowitz | Sep 1994 | A |
5349675 | Fitzgerald et al. | Sep 1994 | A |
5356378 | Doan | Oct 1994 | A |
5360410 | Wacks | Nov 1994 | A |
5361202 | Doue | Nov 1994 | A |
5361758 | Hall et al. | Nov 1994 | A |
5366896 | Margrey et al. | Nov 1994 | A |
5366904 | Qureshi et al. | Nov 1994 | A |
5367555 | Isoyama | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5370612 | Maeda et al. | Dec 1994 | A |
5371687 | Holmes, II et al. | Dec 1994 | A |
5374251 | Smith | Dec 1994 | A |
5374813 | Shipp | Dec 1994 | A |
5374965 | Kanno | Dec 1994 | A |
5375604 | Kelly et al. | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5377864 | Blechl et al. | Jan 1995 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5379214 | Arbuckle et al. | Jan 1995 | A |
5389078 | Zalesky et al. | Feb 1995 | A |
5390238 | Kirk et al. | Feb 1995 | A |
5392951 | Gardner et al. | Feb 1995 | A |
5395320 | Padda et al. | Mar 1995 | A |
5395321 | Kawahara et al. | Mar 1995 | A |
5398336 | Tantry et al. | Mar 1995 | A |
5401059 | Ferrario | Mar 1995 | A |
5404292 | Hendrickson | Apr 1995 | A |
5404384 | Colburn et al. | Apr 1995 | A |
5406473 | Yoshikura et al. | Apr 1995 | A |
5412715 | Volpe | May 1995 | A |
5415167 | Wilk | May 1995 | A |
5416695 | Stutman et al. | May 1995 | A |
5417222 | Dempsey et al. | May 1995 | A |
5420977 | Sztipanovits et al. | May 1995 | A |
5421343 | Feng | Jun 1995 | A |
5423746 | Burkett et al. | Jun 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5431201 | Torchia et al. | Jul 1995 | A |
5431299 | Brewer et al. | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5433736 | Nilsson | Jul 1995 | A |
5438607 | Przygoda, Jr. et al. | Aug 1995 | A |
5440699 | Farrand et al. | Aug 1995 | A |
5441047 | David et al. | Aug 1995 | A |
5445294 | Gardner et al. | Aug 1995 | A |
5445621 | Poli et al. | Aug 1995 | A |
5446868 | Gardea, II et al. | Aug 1995 | A |
5453098 | Botts et al. | Sep 1995 | A |
5455851 | Chaco et al. | Oct 1995 | A |
5458123 | Unger | Oct 1995 | A |
5460294 | Williams | Oct 1995 | A |
5460605 | Tuttle et al. | Oct 1995 | A |
5461665 | Shur et al. | Oct 1995 | A |
5462051 | Oka et al. | Oct 1995 | A |
5464392 | Epstein et al. | Nov 1995 | A |
5465286 | Clare et al. | Nov 1995 | A |
5467773 | Bergelson et al. | Nov 1995 | A |
5468110 | McDonald et al. | Nov 1995 | A |
5469855 | Pompei et al. | Nov 1995 | A |
5471382 | Tallman et al. | Nov 1995 | A |
5474552 | Palti | Dec 1995 | A |
5482043 | Zulauf | Jan 1996 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5485408 | Blomquist | Jan 1996 | A |
5490610 | Pearson | Feb 1996 | A |
5494592 | Latham, Jr. et al. | Feb 1996 | A |
5496265 | Langley et al. | Mar 1996 | A |
5496273 | Pastrone et al. | Mar 1996 | A |
5502944 | Kraft et al. | Apr 1996 | A |
5507412 | Ebert et al. | Apr 1996 | A |
5508912 | Schneiderman | Apr 1996 | A |
5509318 | Gomes | Apr 1996 | A |
5509422 | Fukami | Apr 1996 | A |
5513957 | O'Leary | May 1996 | A |
5514088 | Zakko | May 1996 | A |
5514095 | Brightbill et al. | May 1996 | A |
5515426 | Yacenda et al. | May 1996 | A |
5520450 | Colson, Jr. et al. | May 1996 | A |
5520637 | Pager et al. | May 1996 | A |
5522396 | Langer et al. | Jun 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5526428 | Arnold | Jun 1996 | A |
5528503 | Moore et al. | Jun 1996 | A |
5529063 | Hill | Jun 1996 | A |
5531680 | Dumas et al. | Jul 1996 | A |
5531697 | Olsen et al. | Jul 1996 | A |
5531698 | Olsen | Jul 1996 | A |
5533079 | Colburn et al. | Jul 1996 | A |
5533981 | Mandro et al. | Jul 1996 | A |
5534691 | Holdaway et al. | Jul 1996 | A |
5536084 | Curtis et al. | Jul 1996 | A |
5537313 | Pirelli | Jul 1996 | A |
5537853 | Finburgh et al. | Jul 1996 | A |
5542420 | Goldman et al. | Aug 1996 | A |
5544649 | David et al. | Aug 1996 | A |
5544651 | Wilk | Aug 1996 | A |
5544661 | Davis et al. | Aug 1996 | A |
5545140 | Conero et al. | Aug 1996 | A |
5546580 | Seliger et al. | Aug 1996 | A |
5547470 | Johnson et al. | Aug 1996 | A |
5549117 | Tacklind et al. | Aug 1996 | A |
5549460 | O'Leary | Aug 1996 | A |
5553609 | Chen et al. | Sep 1996 | A |
5558638 | Evers et al. | Sep 1996 | A |
5558640 | Pfeiler et al. | Sep 1996 | A |
5560352 | Heim et al. | Oct 1996 | A |
5562232 | Pearson | Oct 1996 | A |
5562621 | Claude et al. | Oct 1996 | A |
5563347 | Martin et al. | Oct 1996 | A |
5564434 | Halperin et al. | Oct 1996 | A |
5564803 | McDonald et al. | Oct 1996 | A |
5568912 | Minami et al. | Oct 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5569187 | Kaiser | Oct 1996 | A |
5571258 | Pearson | Nov 1996 | A |
5573502 | LeCocq et al. | Nov 1996 | A |
5573506 | Vasko | Nov 1996 | A |
5575632 | Morris et al. | Nov 1996 | A |
5576952 | Stutman et al. | Nov 1996 | A |
5579001 | Dempsey et al. | Nov 1996 | A |
5579378 | Arlinghaus, Jr. | Nov 1996 | A |
5581369 | Righter et al. | Dec 1996 | A |
5581687 | Lyle et al. | Dec 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5583758 | Mcilroy et al. | Dec 1996 | A |
5588815 | Zaleski, II | Dec 1996 | A |
5589932 | Garcia-Rubio et al. | Dec 1996 | A |
5590648 | Mitchell et al. | Jan 1997 | A |
5591344 | Kenley et al. | Jan 1997 | A |
5593267 | McDonald et al. | Jan 1997 | A |
5594637 | Eisenberg et al. | Jan 1997 | A |
5594786 | Chaco et al. | Jan 1997 | A |
5597995 | Williams et al. | Jan 1997 | A |
5598536 | Slaughter, III et al. | Jan 1997 | A |
5601445 | Schipper et al. | Feb 1997 | A |
5609575 | Larson et al. | Mar 1997 | A |
5609576 | Voss et al. | Mar 1997 | A |
5613115 | Gihl et al. | Mar 1997 | A |
5619428 | Lee et al. | Apr 1997 | A |
5619991 | Sloane | Apr 1997 | A |
5623652 | Vora et al. | Apr 1997 | A |
5623925 | Swenson et al. | Apr 1997 | A |
5626144 | Tacklind et al. | May 1997 | A |
5628619 | Wilson | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5631844 | Margrey et al. | May 1997 | A |
5633910 | Cohen | May 1997 | A |
D380260 | Hyman | Jun 1997 | S |
5634893 | Rishton | Jun 1997 | A |
5637082 | Pages et al. | Jun 1997 | A |
5637093 | Hyman et al. | Jun 1997 | A |
5640301 | Roecher et al. | Jun 1997 | A |
5640953 | Bishop et al. | Jun 1997 | A |
5641628 | Bianchi | Jun 1997 | A |
5643193 | Papillon et al. | Jul 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5647853 | Feldmann et al. | Jul 1997 | A |
5647854 | Olsen et al. | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5652566 | Lambert | Jul 1997 | A |
5658240 | Urdahl et al. | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5661978 | Holmes et al. | Sep 1997 | A |
5664270 | Bell et al. | Sep 1997 | A |
5666404 | Ciccotelli et al. | Sep 1997 | A |
D385646 | Chan | Oct 1997 | S |
5678562 | Sellers | Oct 1997 | A |
5678568 | Uchikubo et al. | Oct 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5682526 | Smokoff et al. | Oct 1997 | A |
5683367 | Jordan et al. | Nov 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5687717 | Halpern | Nov 1997 | A |
5687734 | Dempsey et al. | Nov 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5697951 | Harpstead | Dec 1997 | A |
5700998 | Palti | Dec 1997 | A |
5701894 | Cherry et al. | Dec 1997 | A |
5704351 | Mortara et al. | Jan 1998 | A |
5704364 | Saltzstein et al. | Jan 1998 | A |
5704366 | Tacklind et al. | Jan 1998 | A |
5712798 | Langley et al. | Jan 1998 | A |
5712912 | Tomko et al. | Jan 1998 | A |
5713485 | Liff et al. | Feb 1998 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5715823 | Wood et al. | Feb 1998 | A |
5716114 | Holmes et al. | Feb 1998 | A |
5716194 | Butterfield et al. | Feb 1998 | A |
5718562 | Lawless et al. | Feb 1998 | A |
5719761 | Gatti et al. | Feb 1998 | A |
RE35743 | Pearson | Mar 1998 | E |
5724025 | Tavori | Mar 1998 | A |
5724580 | Levin et al. | Mar 1998 | A |
5732709 | Tacklind et al. | Mar 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5735887 | Barreras, Sr. et al. | Apr 1998 | A |
5737539 | Edelson et al. | Apr 1998 | A |
5740185 | Bosse | Apr 1998 | A |
5740800 | Hendrickson et al. | Apr 1998 | A |
5745366 | Higham et al. | Apr 1998 | A |
5745378 | Barker et al. | Apr 1998 | A |
5752917 | Fuchs | May 1998 | A |
5752976 | Duffin et al. | May 1998 | A |
5755563 | Clegg et al. | May 1998 | A |
5758095 | Albaum et al. | May 1998 | A |
5764923 | Tallman et al. | Jun 1998 | A |
5766155 | Hyman et al. | Jun 1998 | A |
5769811 | Stacey et al. | Jun 1998 | A |
5771657 | Lasher et al. | Jun 1998 | A |
5772585 | Lavin et al. | Jun 1998 | A |
5772586 | Heinonen et al. | Jun 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5772637 | Heinzmann et al. | Jun 1998 | A |
5776057 | Swenson et al. | Jul 1998 | A |
5778345 | McCartney | Jul 1998 | A |
5778882 | Raymond et al. | Jul 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5782878 | Morgan et al. | Jul 1998 | A |
5785650 | Akasaka et al. | Jul 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5788851 | Kenley et al. | Aug 1998 | A |
5790409 | Fedor et al. | Aug 1998 | A |
5791342 | Woodard | Aug 1998 | A |
5791880 | Wilson | Aug 1998 | A |
5793861 | Haigh | Aug 1998 | A |
5793969 | Kamentsky et al. | Aug 1998 | A |
5795317 | Brierton et al. | Aug 1998 | A |
5795327 | Wilson et al. | Aug 1998 | A |
5797515 | Liff et al. | Aug 1998 | A |
5800387 | Duffy et al. | Sep 1998 | A |
5801755 | Echerer | Sep 1998 | A |
5803906 | Pratt et al. | Sep 1998 | A |
5805442 | Crater et al. | Sep 1998 | A |
5805454 | Valerino et al. | Sep 1998 | A |
5805456 | Higham et al. | Sep 1998 | A |
5805505 | Zheng et al. | Sep 1998 | A |
5807321 | Stoker et al. | Sep 1998 | A |
5807322 | Lindsey et al. | Sep 1998 | A |
5807336 | Russo et al. | Sep 1998 | A |
5810747 | Brudny et al. | Sep 1998 | A |
5812410 | Lion et al. | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5815566 | Ramot et al. | Sep 1998 | A |
5818528 | Roth et al. | Oct 1998 | A |
5822418 | Yacenda et al. | Oct 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5823949 | Goltra | Oct 1998 | A |
5826237 | Macrae et al. | Oct 1998 | A |
5829438 | Gibbs et al. | Nov 1998 | A |
5832447 | Rieker et al. | Nov 1998 | A |
5832448 | Brown | Nov 1998 | A |
5832450 | Myers et al. | Nov 1998 | A |
5833599 | Schrier et al. | Nov 1998 | A |
5835897 | Dang | Nov 1998 | A |
5836910 | Duffy et al. | Nov 1998 | A |
5841975 | Layne et al. | Nov 1998 | A |
5842841 | Danby et al. | Dec 1998 | A |
5842976 | Williamson | Dec 1998 | A |
5845253 | Rensimer et al. | Dec 1998 | A |
5848593 | McGrady et al. | Dec 1998 | A |
5851186 | Wood et al. | Dec 1998 | A |
5852590 | De La Huerga | Dec 1998 | A |
5853387 | Clegg et al. | Dec 1998 | A |
5855550 | Lai et al. | Jan 1999 | A |
5857967 | Frid et al. | Jan 1999 | A |
5859972 | Subramaniam et al. | Jan 1999 | A |
5865745 | Schmitt et al. | Feb 1999 | A |
5865786 | Sibalis et al. | Feb 1999 | A |
5867821 | Ballantyne et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5876926 | Beecham | Mar 1999 | A |
5880443 | McDonald et al. | Mar 1999 | A |
5882338 | Gray | Mar 1999 | A |
5883370 | Walker et al. | Mar 1999 | A |
5883576 | De La Huerga | Mar 1999 | A |
5884273 | Sattizahn et al. | Mar 1999 | A |
5884457 | Ortiz et al. | Mar 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5891035 | Wood et al. | Apr 1999 | A |
5891734 | Gill et al. | Apr 1999 | A |
5893697 | Zimi et al. | Apr 1999 | A |
5894273 | Meador et al. | Apr 1999 | A |
5895371 | Levitas et al. | Apr 1999 | A |
5897493 | Brown | Apr 1999 | A |
5897530 | Jackson | Apr 1999 | A |
5897989 | Beecham | Apr 1999 | A |
5899665 | Makino et al. | May 1999 | A |
5899855 | Brown | May 1999 | A |
5901150 | Jhuboo et al. | May 1999 | A |
5904668 | Hyman et al. | May 1999 | A |
5905653 | Higham et al. | May 1999 | A |
5907291 | Chen et al. | May 1999 | A |
5907493 | Boyer et al. | May 1999 | A |
5908027 | Butterfield et al. | Jun 1999 | A |
5910107 | Iliff | Jun 1999 | A |
5910252 | Truitt et al. | Jun 1999 | A |
5911132 | Sloane | Jun 1999 | A |
5911687 | Sato et al. | Jun 1999 | A |
5912818 | McGrady et al. | Jun 1999 | A |
5913197 | Kameda | Jun 1999 | A |
5913310 | Brown | Jun 1999 | A |
5915089 | Stevens et al. | Jun 1999 | A |
5915240 | Karpf | Jun 1999 | A |
5919154 | Toays et al. | Jul 1999 | A |
5921938 | Aoyama et al. | Jul 1999 | A |
5923018 | Kameda et al. | Jul 1999 | A |
5924074 | Evans | Jul 1999 | A |
5924103 | Ahmed et al. | Jul 1999 | A |
5927540 | Godlewski | Jul 1999 | A |
5931791 | Saltzstein et al. | Aug 1999 | A |
5935060 | Iliff | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5938413 | Makino et al. | Aug 1999 | A |
5939326 | Chupp et al. | Aug 1999 | A |
5939699 | Perttunen et al. | Aug 1999 | A |
5940306 | Gardner et al. | Aug 1999 | A |
5940802 | Hildebrand et al. | Aug 1999 | A |
5941829 | Saltzstein et al. | Aug 1999 | A |
5941846 | Duffy et al. | Aug 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
5943423 | Muftic | Aug 1999 | A |
5943633 | Wilson et al. | Aug 1999 | A |
5944659 | Flach et al. | Aug 1999 | A |
5945651 | Chorosinski et al. | Aug 1999 | A |
5946083 | Melendez et al. | Aug 1999 | A |
5946659 | Lancelot et al. | Aug 1999 | A |
D414578 | Chen et al. | Sep 1999 | S |
5950006 | Crater et al. | Sep 1999 | A |
5951300 | Brown | Sep 1999 | A |
5951510 | Barak | Sep 1999 | A |
5954640 | Szabo | Sep 1999 | A |
5954885 | Bollish et al. | Sep 1999 | A |
5954971 | Pages et al. | Sep 1999 | A |
5956023 | Lyle et al. | Sep 1999 | A |
5957885 | Bollish et al. | Sep 1999 | A |
5959529 | Kail, IV | Sep 1999 | A |
5960085 | de la Huerga | Sep 1999 | A |
5960403 | Brown | Sep 1999 | A |
5960991 | Ophardt | Oct 1999 | A |
5961446 | Beller et al. | Oct 1999 | A |
5961448 | Swenson et al. | Oct 1999 | A |
5961487 | Davis | Oct 1999 | A |
5961923 | Nova et al. | Oct 1999 | A |
5963641 | Crandall et al. | Oct 1999 | A |
5964700 | Tallman et al. | Oct 1999 | A |
5966304 | Cook et al. | Oct 1999 | A |
5967975 | Ridgeway | Oct 1999 | A |
5970423 | Langley et al. | Oct 1999 | A |
5971593 | McGrady | Oct 1999 | A |
5971921 | Timbel | Oct 1999 | A |
5971948 | Pages et al. | Oct 1999 | A |
5974124 | Schlueter, Jr. et al. | Oct 1999 | A |
5975737 | Crater et al. | Nov 1999 | A |
5980490 | Tsoukalis | Nov 1999 | A |
5983193 | Heinonen et al. | Nov 1999 | A |
5987519 | Peifer et al. | Nov 1999 | A |
5991731 | Colon et al. | Nov 1999 | A |
5993046 | McGrady et al. | Nov 1999 | A |
5993420 | Hyman et al. | Nov 1999 | A |
5995077 | Wilcox et al. | Nov 1999 | A |
5995939 | Berman et al. | Nov 1999 | A |
5995965 | Experton | Nov 1999 | A |
5997167 | Crater et al. | Dec 1999 | A |
5997476 | Brown | Dec 1999 | A |
6003006 | Colella et al. | Dec 1999 | A |
6004020 | Bartur | Dec 1999 | A |
6004276 | Wright et al. | Dec 1999 | A |
6006191 | DiRienzo | Dec 1999 | A |
6006946 | Williams et al. | Dec 1999 | A |
6009333 | Chaco | Dec 1999 | A |
6010454 | Arieff et al. | Jan 2000 | A |
6011858 | Stock et al. | Jan 2000 | A |
6011999 | Holmes | Jan 2000 | A |
6012034 | Hamparian et al. | Jan 2000 | A |
6013057 | Danby et al. | Jan 2000 | A |
6014631 | Teagarden et al. | Jan 2000 | A |
6016444 | John | Jan 2000 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6018713 | Coli et al. | Jan 2000 | A |
6019745 | Gray | Feb 2000 | A |
6021392 | Lester et al. | Feb 2000 | A |
6022315 | Iliff | Feb 2000 | A |
6023522 | Draganoff et al. | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6027217 | McClure et al. | Feb 2000 | A |
6029138 | Khorasani et al. | Feb 2000 | A |
6032119 | Brown et al. | Feb 2000 | A |
6032155 | de la Huerga | Feb 2000 | A |
6033076 | Braeuning et al. | Mar 2000 | A |
6039251 | Holowko et al. | Mar 2000 | A |
6039467 | Holmes | Mar 2000 | A |
6047259 | Campbell et al. | Apr 2000 | A |
6048086 | Valerino | Apr 2000 | A |
6050940 | Braun et al. | Apr 2000 | A |
6055487 | Margery et al. | Apr 2000 | A |
6057758 | Dempsey et al. | May 2000 | A |
6059736 | Tapper | May 2000 | A |
6061603 | Papadopoulos et al. | May 2000 | A |
6065819 | Holmes et al. | May 2000 | A |
6068153 | Young et al. | May 2000 | A |
6068156 | Liff et al. | May 2000 | A |
6073046 | Patel et al. | Jun 2000 | A |
6074345 | van Oostrom et al. | Jun 2000 | A |
6079621 | Vardanyan et al. | Jun 2000 | A |
6080106 | Lloyd et al. | Jun 2000 | A |
6081048 | Bergmann et al. | Jun 2000 | A |
6081786 | Barry et al. | Jun 2000 | A |
6082776 | Feinberg | Jul 2000 | A |
6083206 | Molko | Jul 2000 | A |
6093146 | Filangeri | Jul 2000 | A |
6095985 | Raymond et al. | Aug 2000 | A |
6096561 | Tayi | Aug 2000 | A |
6098892 | Peoples, Jr. | Aug 2000 | A |
6101407 | Groezinger | Aug 2000 | A |
6101478 | Brown | Aug 2000 | A |
6102856 | Groff et al. | Aug 2000 | A |
6108399 | Hernandez-Guerra et al. | Aug 2000 | A |
6108588 | McGrady | Aug 2000 | A |
6109774 | Holmes et al. | Aug 2000 | A |
6112224 | Peifer et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6113554 | Gilcher et al. | Sep 2000 | A |
6116461 | Broadfield et al. | Sep 2000 | A |
6117940 | Mjalli | Sep 2000 | A |
6123524 | Danby et al. | Sep 2000 | A |
6125350 | Dirbas | Sep 2000 | A |
6129517 | Danby et al. | Oct 2000 | A |
6132371 | Dempsey et al. | Oct 2000 | A |
6134504 | Douglas et al. | Oct 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6139177 | Venkatraman et al. | Oct 2000 | A |
6139495 | De La Huerga | Oct 2000 | A |
6141412 | Smith et al. | Oct 2000 | A |
6144922 | Douglas et al. | Nov 2000 | A |
6145695 | Garrigues | Nov 2000 | A |
6146523 | Kenley et al. | Nov 2000 | A |
6148297 | Swor et al. | Nov 2000 | A |
6149063 | Reynolds et al. | Nov 2000 | A |
6151536 | Arnold et al. | Nov 2000 | A |
6152364 | Schoonen et al. | Nov 2000 | A |
6154668 | Pedersen et al. | Nov 2000 | A |
6154726 | Rensimer et al. | Nov 2000 | A |
6157914 | Seto et al. | Dec 2000 | A |
6158965 | Butterfield et al. | Dec 2000 | A |
6160478 | Jacobsen et al. | Dec 2000 | A |
6161095 | Brown | Dec 2000 | A |
6161141 | Dillon | Dec 2000 | A |
6163737 | Fedor et al. | Dec 2000 | A |
6165154 | Gray et al. | Dec 2000 | A |
6168563 | Brown | Jan 2001 | B1 |
6170007 | Venkatraman et al. | Jan 2001 | B1 |
6170746 | Brook et al. | Jan 2001 | B1 |
6171112 | Clark et al. | Jan 2001 | B1 |
6171237 | Avitall et al. | Jan 2001 | B1 |
6171264 | Bader | Jan 2001 | B1 |
6173198 | Schulze et al. | Jan 2001 | B1 |
6175779 | Barrett | Jan 2001 | B1 |
6175977 | Schumacher et al. | Jan 2001 | B1 |
6176392 | William et al. | Jan 2001 | B1 |
6182047 | Dirbas | Jan 2001 | B1 |
6183417 | Geheb et al. | Feb 2001 | B1 |
6186145 | Brown | Feb 2001 | B1 |
6192320 | Margrey et al. | Feb 2001 | B1 |
6193480 | Butterfield | Feb 2001 | B1 |
6195887 | Danby et al. | Mar 2001 | B1 |
6198394 | Jacobsen et al. | Mar 2001 | B1 |
6200264 | Satherley et al. | Mar 2001 | B1 |
6200289 | Hochman et al. | Mar 2001 | B1 |
6202923 | Boyer et al. | Mar 2001 | B1 |
6203495 | Bardy | Mar 2001 | B1 |
6203528 | Decked et al. | Mar 2001 | B1 |
6206238 | Ophardt | Mar 2001 | B1 |
6206829 | Iliff | Mar 2001 | B1 |
6210361 | Kamen et al. | Apr 2001 | B1 |
6213391 | Lewis | Apr 2001 | B1 |
6213738 | Danby et al. | Apr 2001 | B1 |
6213972 | Butterfield et al. | Apr 2001 | B1 |
6219439 | Burger | Apr 2001 | B1 |
6219587 | Ahlin et al. | Apr 2001 | B1 |
6221009 | Doi et al. | Apr 2001 | B1 |
6221011 | Bardy | Apr 2001 | B1 |
6221012 | Maschke et al. | Apr 2001 | B1 |
6222619 | Herron et al. | Apr 2001 | B1 |
6224549 | Drongelen | May 2001 | B1 |
6225901 | Kail, IV | May 2001 | B1 |
6226564 | Stuart | May 2001 | B1 |
6226745 | Wiederhold | May 2001 | B1 |
6230142 | Benigno et al. | May 2001 | B1 |
6230927 | Schoonen et al. | May 2001 | B1 |
6234997 | Kamen et al. | May 2001 | B1 |
6245013 | Minoz et al. | Jun 2001 | B1 |
6246473 | Smith, Jr. et al. | Jun 2001 | B1 |
6248063 | Barnhill et al. | Jun 2001 | B1 |
6248065 | Brown | Jun 2001 | B1 |
6255951 | De La Huerga | Jul 2001 | B1 |
6256643 | Cork et al. | Jul 2001 | B1 |
6256967 | Hebron et al. | Jul 2001 | B1 |
6259355 | Chaco et al. | Jul 2001 | B1 |
6259654 | De La Huerga | Jul 2001 | B1 |
6260021 | Wong et al. | Jul 2001 | B1 |
6266645 | Simpson | Jul 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
D446854 | Cheney, II et al. | Aug 2001 | S |
6270455 | Brown | Aug 2001 | B1 |
6270457 | Bardy | Aug 2001 | B1 |
6272394 | Lipps | Aug 2001 | B1 |
6272505 | De La Huerga | Aug 2001 | B1 |
6277072 | Bardy | Aug 2001 | B1 |
6278999 | Knapp | Aug 2001 | B1 |
6283322 | Liff et al. | Sep 2001 | B1 |
6283944 | McMullen et al. | Sep 2001 | B1 |
6290646 | Cosentino et al. | Sep 2001 | B1 |
6290650 | Butterfield et al. | Sep 2001 | B1 |
6294999 | Yarin et al. | Sep 2001 | B1 |
6295506 | Heinonen | Sep 2001 | B1 |
6304788 | Eady et al. | Oct 2001 | B1 |
6306088 | Krausman et al. | Oct 2001 | B1 |
6307956 | Black | Oct 2001 | B1 |
6308171 | De La Huerga | Oct 2001 | B1 |
6311163 | Sheehan et al. | Oct 2001 | B1 |
6312227 | Davis | Nov 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6314384 | Goetz | Nov 2001 | B1 |
6317719 | Schrier et al. | Nov 2001 | B1 |
6319200 | Lai et al. | Nov 2001 | B1 |
6321203 | Kameda | Nov 2001 | B1 |
6322502 | Schoenberg et al. | Nov 2001 | B1 |
6322504 | Kirshner | Nov 2001 | B1 |
6322515 | Goor et al. | Nov 2001 | B1 |
6330491 | Lion | Dec 2001 | B1 |
6332090 | DeFrank et al. | Dec 2001 | B1 |
RE37531 | Chaco et al. | Jan 2002 | E |
6337631 | Pai et al. | Jan 2002 | B1 |
6338007 | Broadfield et al. | Jan 2002 | B1 |
6339732 | Phoon et al. | Jan 2002 | B1 |
6345260 | Cummings, Jr. et al. | Feb 2002 | B1 |
6346886 | De La Huerga | Feb 2002 | B1 |
6347553 | Morris et al. | Feb 2002 | B1 |
6352200 | Schoonen et al. | Mar 2002 | B1 |
6353817 | Jacobs et al. | Mar 2002 | B1 |
6358225 | Butterfield | Mar 2002 | B1 |
6358237 | Paukovits et al. | Mar 2002 | B1 |
6361263 | Dewey et al. | Mar 2002 | B1 |
6362591 | Moberg | Mar 2002 | B1 |
6363282 | Nichols et al. | Mar 2002 | B1 |
6363290 | Lyle et al. | Mar 2002 | B1 |
6364834 | Reuss et al. | Apr 2002 | B1 |
6368273 | Brown | Apr 2002 | B1 |
6370841 | Chudy et al. | Apr 2002 | B1 |
6381577 | Brown | Apr 2002 | B1 |
6385505 | Lipps | May 2002 | B1 |
6393369 | Carr | May 2002 | B1 |
6397190 | Goetz | May 2002 | B1 |
6401072 | Haudenschild et al. | Jun 2002 | B1 |
6402702 | Gilcher et al. | Jun 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6407335 | Franklin-Lees et al. | Jun 2002 | B1 |
6408330 | DeLaHuerga | Jun 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6421650 | Goetz et al. | Jul 2002 | B1 |
6424996 | Killcommons et al. | Jul 2002 | B1 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6434531 | Lancelot et al. | Aug 2002 | B1 |
6434569 | Tomlinson et al. | Aug 2002 | B1 |
6438451 | Lion | Aug 2002 | B1 |
RE37829 | Charhut et al. | Sep 2002 | E |
6449927 | Hebron et al. | Sep 2002 | B2 |
6450956 | Rappaport et al. | Sep 2002 | B1 |
6458102 | Mann et al. | Oct 2002 | B1 |
6461037 | O'Leary | Oct 2002 | B1 |
6463310 | Swedlow et al. | Oct 2002 | B1 |
6468242 | Wilson et al. | Oct 2002 | B1 |
6470234 | McGrady | Oct 2002 | B1 |
6471089 | Liff et al. | Oct 2002 | B2 |
6471645 | Warkentin et al. | Oct 2002 | B1 |
6471646 | Thede | Oct 2002 | B1 |
6475146 | Frelburger et al. | Nov 2002 | B1 |
6475148 | Jackson et al. | Nov 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6478737 | Bardy | Nov 2002 | B2 |
6485465 | Moberg et al. | Nov 2002 | B2 |
6494831 | Koritzinsky | Dec 2002 | B1 |
6511138 | Gardner et al. | Jan 2003 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6537244 | Paukovits | Mar 2003 | B2 |
6542902 | Dulong et al. | Apr 2003 | B2 |
6542910 | Cork et al. | Apr 2003 | B2 |
6544174 | West et al. | Apr 2003 | B2 |
6544228 | Heitmeier | Apr 2003 | B1 |
6551243 | Bocionek et al. | Apr 2003 | B2 |
6551276 | Mann et al. | Apr 2003 | B1 |
6554791 | Cartledge et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6555986 | Moberg | Apr 2003 | B2 |
6558321 | Burd et al. | May 2003 | B1 |
6561975 | Pool et al. | May 2003 | B1 |
6562001 | Lebel et al. | May 2003 | B2 |
6564104 | Nelson et al. | May 2003 | B2 |
6564105 | Starkweather et al. | May 2003 | B2 |
6564121 | Wallace et al. | May 2003 | B1 |
6571128 | Lebel et al. | May 2003 | B2 |
6575900 | Zweig et al. | Jun 2003 | B1 |
6577899 | Lebel et al. | Jun 2003 | B2 |
6579232 | Sakamaki et al. | Jun 2003 | B2 |
6581069 | Robinson et al. | Jun 2003 | B1 |
6581798 | Liff et al. | Jun 2003 | B2 |
6584336 | Ali et al. | Jun 2003 | B1 |
6585157 | Brandt et al. | Jul 2003 | B2 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6585675 | O×Mahony et al. | Jul 2003 | B1 |
6592551 | Cobb | Jul 2003 | B1 |
6593528 | Franklin-Lees et al. | Jul 2003 | B2 |
6602469 | Maus et al. | Aug 2003 | B1 |
6607485 | Bardy | Aug 2003 | B2 |
6610973 | Davis, III | Aug 2003 | B1 |
6613009 | Bainbridge et al. | Sep 2003 | B1 |
6616633 | Butterfield et al. | Sep 2003 | B1 |
6635014 | Starkweather et al. | Oct 2003 | B2 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6659948 | Lebel et al. | Dec 2003 | B2 |
6664893 | Eveland et al. | Dec 2003 | B1 |
6668196 | Villegas et al. | Dec 2003 | B1 |
6669663 | Thompson | Dec 2003 | B1 |
6673314 | Burbank et al. | Jan 2004 | B1 |
6687546 | Lebel et al. | Jan 2004 | B2 |
6689091 | Bui et al. | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6694334 | DuLong et al. | Feb 2004 | B2 |
6711460 | Reese | Mar 2004 | B1 |
6731324 | Levy | May 2004 | B2 |
6733447 | Lai et al. | May 2004 | B2 |
6735497 | Wallace et al. | May 2004 | B2 |
6740075 | Lebel et al. | May 2004 | B2 |
6746398 | Hervy et al. | Jun 2004 | B2 |
6758810 | Lebel et al. | Jul 2004 | B2 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6771369 | Rzasa et al. | Aug 2004 | B2 |
6775602 | Gordon, Jr. et al. | Aug 2004 | B2 |
6776304 | Liff et al. | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6804656 | Rosenfeld et al. | Oct 2004 | B1 |
6810290 | Lebel et al. | Oct 2004 | B2 |
6811533 | Lebel et al. | Nov 2004 | B2 |
6811534 | Bowman, IV et al. | Nov 2004 | B2 |
6811707 | Rovatti et al. | Nov 2004 | B2 |
6813473 | Bruker | Nov 2004 | B1 |
6813519 | Lebel et al. | Nov 2004 | B2 |
6814255 | Liff et al. | Nov 2004 | B2 |
6820093 | De La Huerga | Nov 2004 | B2 |
6842736 | Brzozowski | Jan 2005 | B1 |
6847861 | Lunak et al. | Jan 2005 | B2 |
6854088 | Massengale et al. | Feb 2005 | B2 |
6871211 | Labounty et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6877530 | Osborne et al. | Apr 2005 | B2 |
6880034 | Manke et al. | Apr 2005 | B2 |
6885288 | Pincus | Apr 2005 | B2 |
6887201 | Bardy | May 2005 | B2 |
6892941 | Rosenblum | May 2005 | B2 |
6912549 | Rotter et al. | Jun 2005 | B2 |
6913590 | Sorenson et al. | Jul 2005 | B2 |
6915265 | Johnson | Jul 2005 | B1 |
6915823 | Osborne et al. | Jul 2005 | B2 |
6928452 | De La Huerga | Aug 2005 | B2 |
6950708 | Bowman, IV et al. | Sep 2005 | B2 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6975924 | Kircher et al. | Dec 2005 | B2 |
6976628 | Krupa | Dec 2005 | B2 |
6979306 | Moll | Dec 2005 | B2 |
6980958 | Surwit et al. | Dec 2005 | B1 |
6981644 | Cheong et al. | Jan 2006 | B2 |
6985870 | Martucci et al. | Jan 2006 | B2 |
6991002 | Osborne et al. | Jan 2006 | B2 |
6995664 | Darling | Feb 2006 | B1 |
7006893 | Hart et al. | Feb 2006 | B2 |
7015806 | Naidoo et al. | Mar 2006 | B2 |
7017622 | Osborne et al. | Mar 2006 | B2 |
7017623 | Tribble et al. | Mar 2006 | B2 |
7028723 | Alouani et al. | Apr 2006 | B1 |
7096212 | Tribble et al. | Aug 2006 | B2 |
7117902 | Osborne | Oct 2006 | B2 |
7151982 | Liff et al. | Dec 2006 | B2 |
7194336 | DiGianfilippo et al. | Mar 2007 | B2 |
7209891 | Addy et al. | Apr 2007 | B1 |
7240699 | Osborne et al. | Jul 2007 | B2 |
7255680 | Gharib | Aug 2007 | B1 |
7277579 | Huang | Oct 2007 | B2 |
7277757 | Casavant et al. | Oct 2007 | B2 |
7317967 | DiGianfilippo et al. | Jan 2008 | B2 |
7321861 | Oon | Jan 2008 | B1 |
7343224 | DiGianfilippo et al. | Mar 2008 | B2 |
7403901 | Carley et al. | Jul 2008 | B1 |
7427002 | Liff et al. | Sep 2008 | B2 |
7493263 | Helmus et al. | Feb 2009 | B2 |
7499581 | Tribble et al. | Mar 2009 | B2 |
7509280 | Haudenschild | Mar 2009 | B1 |
7555557 | Bradley et al. | Jun 2009 | B2 |
7561312 | Proudfoot et al. | Jul 2009 | B1 |
7581953 | Lehmann et al. | Sep 2009 | B2 |
7599516 | Limer et al. | Oct 2009 | B2 |
7610115 | Rob et al. | Oct 2009 | B2 |
7630908 | Amrien et al. | Dec 2009 | B1 |
7636718 | Steen et al. | Dec 2009 | B1 |
7672859 | Louie et al. | Mar 2010 | B1 |
7698019 | Moncrief et al. | Apr 2010 | B2 |
7698154 | Marchosky | Apr 2010 | B2 |
7734478 | Goodall et al. | Jun 2010 | B2 |
7753085 | Tribble et al. | Jul 2010 | B2 |
7769601 | Bleser et al. | Aug 2010 | B1 |
7783383 | Eliuk et al. | Aug 2010 | B2 |
D624225 | Federico et al. | Sep 2010 | S |
7801642 | Ansari et al. | Sep 2010 | B2 |
7847970 | McGrady | Dec 2010 | B1 |
7853621 | Guo | Dec 2010 | B2 |
7904822 | Monteleone et al. | Mar 2011 | B2 |
7931859 | Mlodzinski et al. | Apr 2011 | B2 |
7937290 | Bahir | May 2011 | B2 |
7986369 | Burns | Jul 2011 | B1 |
7991507 | Liff et al. | Aug 2011 | B2 |
8170271 | Chen | May 2012 | B2 |
8191339 | Tribble et al. | Jun 2012 | B2 |
8215557 | Reno et al. | Jul 2012 | B1 |
8220503 | Tribble et al. | Jul 2012 | B2 |
8225824 | Eliuk et al. | Jul 2012 | B2 |
D667961 | Marmier | Sep 2012 | S |
8267129 | Doherty et al. | Sep 2012 | B2 |
8271138 | Eliuk et al. | Sep 2012 | B2 |
8280549 | Liff et al. | Oct 2012 | B2 |
8284305 | Newcomb et al. | Oct 2012 | B2 |
8374887 | Alexander | Feb 2013 | B1 |
8386070 | Eliuk et al. | Feb 2013 | B2 |
8548824 | daCosta | Oct 2013 | B1 |
8554579 | Tribble et al. | Oct 2013 | B2 |
D693480 | Spiess et al. | Nov 2013 | S |
8595206 | Ansari | Nov 2013 | B1 |
8666541 | Ansari et al. | Mar 2014 | B1 |
8678047 | Tribble et al. | Mar 2014 | B2 |
8719217 | Vivalda | May 2014 | B1 |
D715958 | Bossart et al. | Oct 2014 | S |
9053218 | Osborne et al. | Jun 2015 | B2 |
D733480 | Shao | Jul 2015 | S |
D738152 | Grasselli et al. | Sep 2015 | S |
D753428 | Shao | Apr 2016 | S |
9362969 | Burgess et al. | Jun 2016 | B1 |
9382021 | Tribble et al. | Jul 2016 | B2 |
9662273 | Ranalletta et al. | May 2017 | B2 |
9930297 | Alexander et al. | Mar 2018 | B2 |
9956145 | Thompson et al. | May 2018 | B2 |
20010001237 | Stroda et al. | May 2001 | A1 |
20010003177 | Schena et al. | Jun 2001 | A1 |
20010007053 | Bardy | Jul 2001 | A1 |
20010007932 | Kamen et al. | Jul 2001 | A1 |
20010011153 | Bardy | Aug 2001 | A1 |
20010016699 | Burbank et al. | Aug 2001 | A1 |
20010017817 | De La Huerga | Aug 2001 | A1 |
20010021801 | Bardy | Sep 2001 | A1 |
20010025138 | Bardy | Sep 2001 | A1 |
20010025156 | Bui et al. | Sep 2001 | A1 |
20010027634 | Hebron et al. | Oct 2001 | A1 |
20010028308 | De La Huerga | Oct 2001 | A1 |
20010030234 | Wiklof | Oct 2001 | A1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20010032101 | Statius Muller | Oct 2001 | A1 |
20010034502 | Moberg et al. | Oct 2001 | A1 |
20010034614 | Fletcher-Haynes et al. | Oct 2001 | A1 |
20010034616 | Giannini | Oct 2001 | A1 |
20010037057 | Bardy | Nov 2001 | A1 |
20010037083 | Hartlaub et al. | Nov 2001 | A1 |
20010037217 | Abensour et al. | Nov 2001 | A1 |
20010037220 | Merry et al. | Nov 2001 | A1 |
20010041920 | Starkweather et al. | Nov 2001 | A1 |
20010044588 | Mault | Nov 2001 | A1 |
20010044731 | Coffman et al. | Nov 2001 | A1 |
20010047125 | Quy | Nov 2001 | A1 |
20010051764 | Bardy | Dec 2001 | A1 |
20010053885 | Gielen et al. | Dec 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020002473 | Schrier et al. | Jan 2002 | A1 |
20020004645 | Carlisle et al. | Jan 2002 | A1 |
20020007285 | Rappaport | Jan 2002 | A1 |
20020010568 | Rubbert et al. | Jan 2002 | A1 |
20020010679 | Felsher | Jan 2002 | A1 |
20020013612 | Whitehurst | Jan 2002 | A1 |
20020016567 | Hochman et al. | Feb 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020016719 | Nemeth et al. | Feb 2002 | A1 |
20020016722 | Kameda | Feb 2002 | A1 |
20020019606 | Lebel et al. | Feb 2002 | A1 |
20020019748 | Brown | Feb 2002 | A1 |
20020022776 | Bardy | Feb 2002 | A1 |
20020025796 | Taylor et al. | Feb 2002 | A1 |
20020026104 | Bardy | Feb 2002 | A1 |
20020029157 | Marchosky | Mar 2002 | A1 |
20020029776 | Blomquist | Mar 2002 | A1 |
20020032582 | Feeney et al. | Mar 2002 | A1 |
20020032602 | Lanzillo, Jr. et al. | Mar 2002 | A1 |
20020038392 | De La Huerga | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020044043 | Chaco et al. | Apr 2002 | A1 |
20020046062 | Kameda | Apr 2002 | A1 |
20020046185 | Villart et al. | Apr 2002 | A1 |
20020046346 | Evans | Apr 2002 | A1 |
20020052539 | Haller et al. | May 2002 | A1 |
20020052542 | Bardy | May 2002 | A1 |
20020052574 | Hochman et al. | May 2002 | A1 |
20020062227 | Yuyama | May 2002 | A1 |
20020062229 | Alban et al. | May 2002 | A1 |
20020065540 | Lebel et al. | May 2002 | A1 |
20020065686 | Monteleone et al. | May 2002 | A1 |
20020067273 | Jaques et al. | Jun 2002 | A1 |
20020072733 | Flaherty | Jun 2002 | A1 |
20020073250 | Ommering | Jun 2002 | A1 |
20020077852 | Ford et al. | Jun 2002 | A1 |
20020077865 | Sullivan | Jun 2002 | A1 |
20020082480 | Riff et al. | Jun 2002 | A1 |
20020082865 | Bianco et al. | Jun 2002 | A1 |
20020082868 | Pories et al. | Jun 2002 | A1 |
20020084904 | De La Huerga | Jul 2002 | A1 |
20020087120 | Rogers et al. | Jul 2002 | A1 |
20020091309 | Auer | Jul 2002 | A1 |
20020099283 | Christ et al. | Jul 2002 | A1 |
20020099301 | Bardy | Jul 2002 | A1 |
20020100762 | Liff et al. | Aug 2002 | A1 |
20020107476 | Mann et al. | Aug 2002 | A1 |
20020107707 | Naparstek et al. | Aug 2002 | A1 |
20020116226 | Auer et al. | Aug 2002 | A1 |
20020116509 | De La Huerga | Aug 2002 | A1 |
20020128606 | Cowan et al. | Sep 2002 | A1 |
20020128871 | Adamson et al. | Sep 2002 | A1 |
20020128880 | Kunikiyo | Sep 2002 | A1 |
20020133377 | Brown | Sep 2002 | A1 |
20020140675 | Ali et al. | Oct 2002 | A1 |
20020143254 | Maruyama | Oct 2002 | A1 |
20020156462 | Stultz | Oct 2002 | A1 |
20020158128 | Ashiuro | Oct 2002 | A1 |
20020165491 | Reilly | Nov 2002 | A1 |
20020169636 | Eggers et al. | Nov 2002 | A1 |
20020173875 | Wallace et al. | Nov 2002 | A1 |
20020188467 | Eke | Dec 2002 | A1 |
20020198473 | Kumar et al. | Dec 2002 | A1 |
20020198513 | Lebel et al. | Dec 2002 | A1 |
20020198624 | Greenwald | Dec 2002 | A1 |
20030006878 | Chung | Jan 2003 | A1 |
20030023177 | Bardy | Jan 2003 | A1 |
20030033532 | Marks | Feb 2003 | A1 |
20030036783 | Bauhahn et al. | Feb 2003 | A1 |
20030046114 | Davies et al. | Mar 2003 | A1 |
20030046280 | Rotter et al. | Mar 2003 | A1 |
20030046439 | Manke et al. | Mar 2003 | A1 |
20030050621 | Lebel et al. | Mar 2003 | A1 |
20030050731 | Rosenblum | Mar 2003 | A1 |
20030052787 | Zerhusen | Mar 2003 | A1 |
20030060753 | Starkweather et al. | Mar 2003 | A1 |
20030060754 | Reilly | Mar 2003 | A1 |
20030060765 | Campbell et al. | Mar 2003 | A1 |
20030060768 | Kiyatake | Mar 2003 | A1 |
20030065287 | Spohn et al. | Apr 2003 | A1 |
20030076736 | Buker et al. | Apr 2003 | A1 |
20030078534 | Hochman et al. | Apr 2003 | A1 |
20030079746 | Hickle | May 2003 | A1 |
20030083901 | Bosch et al. | May 2003 | A1 |
20030088238 | Poulsen et al. | May 2003 | A1 |
20030097092 | Flaherty | May 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030117580 | Franz et al. | Jun 2003 | A1 |
20030125609 | Becker | Jul 2003 | A1 |
20030125611 | Bardy | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030144878 | Wilkes et al. | Jul 2003 | A1 |
20030149599 | Goodall et al. | Aug 2003 | A1 |
20030154108 | Fletcher-Haynes et al. | Aug 2003 | A1 |
20030158508 | DiGianfilippo | Aug 2003 | A1 |
20030160683 | Blomquist | Aug 2003 | A1 |
20030163088 | Blomquist | Aug 2003 | A1 |
20030163223 | Blomquist | Aug 2003 | A1 |
20030163789 | Blomquist | Aug 2003 | A1 |
20030167035 | Flaherty et al. | Sep 2003 | A1 |
20030176933 | Lebel et al. | Sep 2003 | A1 |
20030179287 | Kozic et al. | Sep 2003 | A1 |
20030181851 | Mann et al. | Sep 2003 | A1 |
20030182164 | Shabot | Sep 2003 | A1 |
20030195397 | Bardy | Oct 2003 | A1 |
20030200117 | Manetta et al. | Oct 2003 | A1 |
20030201697 | Richardson | Oct 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030225596 | Richardson et al. | Dec 2003 | A1 |
20030225728 | Moura | Dec 2003 | A1 |
20030231803 | Huang | Dec 2003 | A1 |
20040002874 | Shaffer et al. | Jan 2004 | A1 |
20040017475 | Akers et al. | Jan 2004 | A1 |
20040019607 | Moubayed et al. | Jan 2004 | A1 |
20040115132 | Brown | Jan 2004 | A1 |
20040039260 | Bardy | Feb 2004 | A1 |
20040039264 | Bardy | Feb 2004 | A1 |
20040051368 | Caputo et al. | Mar 2004 | A1 |
20040055611 | Penny et al. | Mar 2004 | A1 |
20040064343 | Korpman et al. | Apr 2004 | A1 |
20040073329 | Engleson | Apr 2004 | A1 |
20040088187 | Chudy et al. | May 2004 | A1 |
20040088374 | Webb et al. | May 2004 | A1 |
20040111293 | Firanek et al. | Jun 2004 | A1 |
20040116862 | Ray | Jun 2004 | A1 |
20040117215 | Marchosky | Jun 2004 | A1 |
20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
20040129616 | Mori et al. | Jul 2004 | A1 |
20040148195 | Kalies | Jul 2004 | A1 |
20040158193 | Bui et al. | Aug 2004 | A1 |
20040172283 | Vanderveen et al. | Sep 2004 | A1 |
20040172289 | Kozic et al. | Sep 2004 | A1 |
20040172300 | Mihai et al. | Sep 2004 | A1 |
20040193328 | Zaitsu et al. | Sep 2004 | A1 |
20040193453 | Butterfield et al. | Sep 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040204954 | Lacko | Oct 2004 | A1 |
20040215490 | Duchon et al. | Oct 2004 | A1 |
20040220829 | Baharav et al. | Nov 2004 | A1 |
20040225528 | Brock | Nov 2004 | A1 |
20040235446 | Flaherty et al. | Nov 2004 | A1 |
20040236630 | Kost et al. | Nov 2004 | A1 |
20040248295 | Katsuhiko et al. | Dec 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20040260577 | Dahlin et al. | Dec 2004 | A1 |
20050001033 | Cheong et al. | Jan 2005 | A1 |
20050017864 | Tsoukalis | Jan 2005 | A1 |
20050021369 | Cohen | Jan 2005 | A1 |
20050033124 | Kelly et al. | Feb 2005 | A1 |
20050033773 | Roberge et al. | Feb 2005 | A1 |
20050038680 | McMahon | Feb 2005 | A1 |
20050039742 | Hickle | Feb 2005 | A1 |
20050043665 | Vinci et al. | Feb 2005 | A1 |
20050045548 | Brugger et al. | Mar 2005 | A1 |
20050054923 | Pan | Mar 2005 | A1 |
20050060372 | DeBettencourt et al. | Mar 2005 | A1 |
20050065823 | Ramraj | Mar 2005 | A1 |
20050080651 | Morrison et al. | Apr 2005 | A1 |
20050108044 | Koster | May 2005 | A1 |
20050187794 | Kimak | Aug 2005 | A1 |
20050209737 | Kircher | Sep 2005 | A1 |
20050228238 | Monitzer | Oct 2005 | A1 |
20050279419 | Tribble et al. | Dec 2005 | A1 |
20060084042 | Weaver et al. | Apr 2006 | A1 |
20060124656 | Popovich, Jr. | Jun 2006 | A1 |
20060136095 | Rob et al. | Jun 2006 | A1 |
20060149416 | Mohapatra et al. | Jul 2006 | A1 |
20060161294 | DiMaggio | Jul 2006 | A1 |
20060173714 | Grotzinger, Jr. | Aug 2006 | A1 |
20060178578 | Tribble et al. | Aug 2006 | A1 |
20060181391 | McNeill et al. | Aug 2006 | A1 |
20060235881 | Masarie et al. | Oct 2006 | A1 |
20070043767 | Osborne et al. | Feb 2007 | A1 |
20070047980 | Limer et al. | Mar 2007 | A1 |
20070088568 | Goodall et al. | Apr 2007 | A1 |
20070100660 | Carosso | May 2007 | A1 |
20070100662 | Suwalski | May 2007 | A1 |
20070110305 | Corcoran et al. | May 2007 | A1 |
20070125442 | Tribble et al. | Jun 2007 | A1 |
20070168228 | Lawless | Jul 2007 | A1 |
20070179806 | Knowlton et al. | Aug 2007 | A1 |
20070189597 | Limer et al. | Aug 2007 | A1 |
20070192139 | Cookson et al. | Aug 2007 | A1 |
20070216998 | Sander | Sep 2007 | A1 |
20070239482 | Finn et al. | Oct 2007 | A1 |
20070239997 | Qu et al. | Oct 2007 | A1 |
20080046292 | Myers et al. | Feb 2008 | A1 |
20080056556 | Eller et al. | Mar 2008 | A1 |
20080059228 | Bossi et al. | Mar 2008 | A1 |
20080091467 | Moncrief et al. | Apr 2008 | A1 |
20080119958 | Bear et al. | May 2008 | A1 |
20080125897 | DiGianfilippo et al. | May 2008 | A1 |
20080147554 | Stevens et al. | Jun 2008 | A1 |
20080195246 | Tribble et al. | Aug 2008 | A1 |
20080306926 | Friedlander et al. | Dec 2008 | A1 |
20090024414 | Mansour | Jan 2009 | A1 |
20090080408 | Natoli et al. | Mar 2009 | A1 |
20090097368 | Vlutters et al. | Apr 2009 | A1 |
20090138340 | Borr et al. | May 2009 | A1 |
20090188937 | Kim | Jul 2009 | A1 |
20090205877 | Claypool | Aug 2009 | A1 |
20090210252 | Silver | Aug 2009 | A1 |
20090216560 | Siegel | Aug 2009 | A1 |
20090235194 | Arndt et al. | Sep 2009 | A1 |
20090258331 | Do et al. | Oct 2009 | A1 |
20090285762 | Flower | Nov 2009 | A1 |
20090313044 | Hague et al. | Dec 2009 | A1 |
20090323170 | Lin | Dec 2009 | A1 |
20090324032 | Chen | Dec 2009 | A1 |
20100017031 | Rob et al. | Jan 2010 | A1 |
20100091281 | Suzuki | Apr 2010 | A1 |
20100094653 | Tribble et al. | Apr 2010 | A1 |
20100128165 | Newcomb et al. | May 2010 | A1 |
20100157293 | Rzasa et al. | Jun 2010 | A9 |
20100185456 | Kansal | Jul 2010 | A1 |
20100241270 | Eliuk et al. | Sep 2010 | A1 |
20110119088 | Gunn | May 2011 | A1 |
20110191121 | Fioravanti | Aug 2011 | A1 |
20110202366 | Akers et al. | Aug 2011 | A1 |
20110208350 | Eliuk et al. | Aug 2011 | A1 |
20110267465 | Alexander et al. | Nov 2011 | A1 |
20120022885 | Murayama | Jan 2012 | A1 |
20120097290 | Mikhaeil | Apr 2012 | A1 |
20120200596 | Gotou et al. | Aug 2012 | A1 |
20120211565 | Colavito et al. | Aug 2012 | A1 |
20120303388 | Vishnubhatla et al. | Nov 2012 | A1 |
20130079581 | Agamaite et al. | Mar 2013 | A1 |
20130090947 | Nockley | Apr 2013 | A1 |
20130136330 | Takagi | May 2013 | A1 |
20130197445 | Schabbach et al. | Aug 2013 | A1 |
20130262138 | Jaskela et al. | Oct 2013 | A1 |
20130279774 | Helgason et al. | Oct 2013 | A1 |
20130304510 | Chan et al. | Nov 2013 | A1 |
20130314535 | Yuyama et al. | Nov 2013 | A1 |
20130342676 | Amano | Dec 2013 | A1 |
20140022569 | Matsui et al. | Jan 2014 | A1 |
20140067407 | Sathe | Mar 2014 | A1 |
20140156064 | Crawford et al. | Jun 2014 | A1 |
20140156294 | Tribble et al. | Jun 2014 | A1 |
20140214436 | Utech et al. | Jul 2014 | A1 |
20140350950 | Jaskela et al. | Nov 2014 | A1 |
20150205932 | Tribble | Jul 2015 | A1 |
20150227719 | Ranalletta | Aug 2015 | A1 |
20150272320 | Ranalletta et al. | Oct 2015 | A1 |
20150278477 | Tribble | Oct 2015 | A1 |
20150286799 | Padmani | Oct 2015 | A1 |
20160072985 | Sandmann et al. | Mar 2016 | A1 |
20160092638 | Padmani | Mar 2016 | A1 |
20160092639 | Padmani | Mar 2016 | A1 |
20160140315 | Diaz et al. | May 2016 | A1 |
20160210437 | Padmani et al. | Jul 2016 | A1 |
20160371462 | Wallen | Dec 2016 | A1 |
20170372034 | Tribble | Dec 2017 | A1 |
Number | Date | Country |
---|---|---|
1516257 | May 1999 | CN |
2440518 | Aug 2001 | CN |
1131076 | Dec 2003 | CN |
0237588 | Sep 1987 | EP |
0462466 | Dec 1991 | EP |
0505627 | Sep 1992 | EP |
0522527 | Jan 1993 | EP |
0439355 | Sep 1994 | EP |
0844581 | May 1998 | EP |
0960627 | Dec 1999 | EP |
0970655 | Jan 2000 | EP |
1072994 | Feb 2001 | EP |
1107158 | Jun 2001 | EP |
1097671 | Feb 2003 | EP |
994977 | Jun 1965 | GB |
2210713 | Feb 1987 | GB |
2279784 | Jan 1995 | GB |
2285135 | Jun 1995 | GB |
2379037 | Feb 2003 | GB |
53137644 | Dec 1978 | JP |
61066950 | Apr 1986 | JP |
63068133 | Mar 1988 | JP |
2111375 | Apr 1990 | JP |
3423055 | Jan 1994 | JP |
6086813 | Mar 1994 | JP |
06327636 | Nov 1994 | JP |
07204253 | Aug 1995 | JP |
104585 | Jan 1998 | JP |
10014890 | Jan 1998 | JP |
10079770 | Mar 1998 | JP |
2000036032 | Feb 2000 | JP |
03055131 | Apr 2000 | JP |
2002011095 | Jan 2002 | JP |
2002092181 | Mar 2002 | JP |
2002520718 | Jul 2002 | JP |
2003022322 | Jan 2003 | JP |
2004078970 | Mar 2004 | JP |
2004326436 | Nov 2004 | JP |
2004340770 | Dec 2004 | JP |
2005252710 | Sep 2005 | JP |
2005284703 | Oct 2005 | JP |
2005284703 | Oct 2005 | JP |
2006033291 | Feb 2006 | JP |
2006334062 | Dec 2006 | JP |
2007198934 | Aug 2007 | JP |
2008139201 | Jun 2008 | JP |
4276654 | Jun 2009 | JP |
2009265827 | Nov 2009 | JP |
2010056619 | Mar 2010 | JP |
2010170504 | Aug 2010 | JP |
2010533927 | Oct 2010 | JP |
2011151430 | Aug 2011 | JP |
2012078265 | Apr 2012 | JP |
5342197 | Nov 2013 | JP |
5747150 | Jul 2015 | JP |
6086813 | Mar 2017 | JP |
20000036642 | Jul 2000 | KR |
1020000036642 | Jul 2000 | KR |
20010094703 | Nov 2001 | KR |
1020010094703 | Nov 2001 | KR |
20050054379 | Dec 2003 | KR |
20110115927 | Oct 2011 | KR |
1020110115927 | Oct 2011 | KR |
20130001500 | Jan 2013 | KR |
WO8400493 | Feb 1984 | WO |
WO9524010 | Sep 1995 | WO |
WO9634291 | Oct 1996 | WO |
WO9741525 | Nov 1997 | WO |
WO9814275 | Apr 1998 | WO |
WO9815092 | Apr 1998 | WO |
WO9824358 | Jun 1998 | WO |
WO9833433 | Aug 1998 | WO |
WO9859487 | Dec 1998 | WO |
WO9904043 | Jan 1999 | WO |
WO9910029 | Mar 1999 | WO |
WO9942933 | Aug 1999 | WO |
WO9944162 | Sep 1999 | WO |
WO9959472 | Nov 1999 | WO |
WO0013588 | Mar 2000 | WO |
WO0029983 | May 2000 | WO |
WO0043941 | Jul 2000 | WO |
WO0052437 | Sep 2000 | WO |
WO0052626 | Sep 2000 | WO |
WO0057339 | Sep 2000 | WO |
WO0060449 | Oct 2000 | WO |
WO0069331 | Nov 2000 | WO |
WO0072181 | Nov 2000 | WO |
WO0078374 | Dec 2000 | WO |
WO0101305 | Jan 2001 | WO |
WO0102979 | Jan 2001 | WO |
WO0106468 | Jan 2001 | WO |
WO0145774 | Jun 2001 | WO |
WO0217777 | Jul 2002 | WO |
WO02091276 | Nov 2002 | WO |
WO03025826 | Mar 2003 | WO |
WO03094073 | Nov 2003 | WO |
WO2004070557 | Aug 2004 | WO |
WO2004070994 | Aug 2004 | WO |
WO-2005043440 | May 2005 | WO |
Entry |
---|
Extended European Search Report (EESR) dated Jun. 11, 2018 in corresponding EP Application No. 15865852.6; (10 Pages). |
Written Opinion dated Apr. 4, 2018 in corresponding Singapore Patent Application No. 11201704359V. |
AHRQ Health Information Technology Program—Update 2005-06 Fact Sheet,, http://www.ahrq.gov/research/findings/factsheets/it/hitfact/index.html—3 pages. |
Albert A. Cook, “An integrated nursing-pharmacy approach to a computerized medication dispensing/administration system,” Hospital Pharmacy, May 1985, pp. 321-325, vol. 20, JB Lippincott Company, Philadelphia, PA. |
Allan T. Pryor, “Current State of Computer-based Patient Record Systems,” Aspects of the Computer-based Patient Record, 1992, pp. 67-82, Springer-Verlag, New York, NY. |
Anderson, Howard “A Narrative on the History of the Development of Telepharmacy in North Dakota from the Board of Pharmacy's Perspective Recorded by Excerpts from Board Minutes”, Feb. 2006. |
Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999, pp. 1404-1405. |
Ann Slone Endo, “Using Computers in Newborn Intensive Care Settings,” American Journal of Nursing, Jul. 1981, pp. 1336-1337. |
Anonymous, “Chains covet customized pharmacy integration” Drug Store New, Aug. 18, 2003, vol. 25, No. 10—p. 73. |
Automated Dispensing Technologies: Directory of Vendors, http://pharmacyautomation.com/vendors.html, Jun. 5, 2003—3 pages. |
Auto Syringe® AS40A Infusion Pump Technical Manual, 1995, 89 pages, Baxter Healthcare Corporation, Deerfield, IL. |
Auto Syringe® AS40A: Model AS40A Infusion Pump Operation Manual, undated, 78 pages, Baxter Healthcare Corporation, Deerfield, IL. |
Baxa Corporation, DoseEdge The Leading Edge in Dose Management, Brochure, published copyright date 2010—5 pages. |
Baxa Corporation, Product Catalog 2010-2011, published at least by Sep. 15, 2012, https://web.archive.org/web/20120915210739http://www.baxa.com/resources/docs/BaxaCatalog.pdf (52 pages). |
Bell Atlantic Healthcare Systems, Inc., court exhibit, StatLan Functions and Features, Specification, release 3.5, dated Nov. 12, 1992, 49 pages. |
Ben Schneiderman, “Designing the User Interface: Strategies for Effective Human-Computer Interaction,” 2d Ed., 1992, Chapter 5: Direct Manipulation (56 pages), Addison-Wesley Publishing Company. |
“Block Medical: Growing with Home Infusion Therapy,” taken from INVIVO, The Business and Medicine Report, Apr. 1991, pp. 7-9. |
Bynum et al., “The Effect of Telepharmacy Counseling on Metered-Dose Inhaler Technique among Adolescents with Asthma in Rural Arkansas”, Telemedicine Journal and e-health, vol. 7, No. 3, 2001, Mary AnnLiebert, Inc., pp. 207-218. |
Cabral, Jr. et al., “Multmedia Systems for Telemedicine Systems for Telemedicine and Their Communications Requirements,” IEEE Communications Magazine Jul. 1996, pp. 20-27. |
Cardinal Health Introduces Rxe-source(SM) to Address Pharmacist Labor Shortage and Medication Safety Challenges at Hospitals. PR Newswire, Feb. 25, 2003—5 pages. |
Casey, Michelle M. et al., “Pharmacist Staffing and the Use of Technology in Small Rural Hospitals: Implications for Medication Safety” Upper Midwest Rural Health Research Center, Dec. 2005—51 pages. |
Cato Reference Manual, Support for Trial Version (Abridged), Vienna, May 2004 Jun. 1, 2004. |
Cato Reference Manual, Vienna, May 2005 May 1, 2005. |
Charles Safran, M.D. et al., “Computer-Based Support for Clinical Decision Making,” Clinical Computin, vol. 7, No. 5 (1990), pp. 319-322. |
Clayton M. Curtis, “A Computer-based Patient Record Emerging from the Public Sector: The Decentralized Hospital Computer Program,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 75-132, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
Clement J. McDonald, M.D. et al, “The Three-Legged Stool: Regenstrief Institute for Health Care,” Third Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1997, pp. 131-158, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
Clement J. McDonald, M.D. et al., The Regenstrief Medical Record System: 20 Years of Experience in Hospitals, Clinics, and Neighborhood Health Centers,: M.D. Computing, 1992 pp. 206-217, vol. 9, No. 4, Springer-Verlag, New York, NY. |
Clifton, G. Dennis et al., “Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing” Am J Health-Syst Pharm, vol. 60, Dec. 15, 2003 oe pp. 2577-2582. |
Dan Murphy, “Nuclear Pharmacy Primer”, Radiation Protection Management, vol. 20, No. 5 (2003), pp. 1-10. |
Dan Scheraga; “Tech firms answer chain pharmacy's call for productivity,” Drug Store News; Dec. 15, 2003; 25, 17; ProQuest Research Library, p. 31-32. |
Daniel Andresen et al., “Scalability Issues for High Performance Digital Libraries on the World Wide Web,” Proceedings of ADL '96, 1996, pp. 139-148, IEEE. |
Daniel J. Nigrin et al., “Glucoweb: A Case Study of Secure, Remote Biomonitoring and Communication,” Proceedings of the 2000, 5 pages, American Medical Informatics Association, Bethesda, MD. |
Darryl V. Wareham et al., “Combination Medication Cart and Computer Terminal in Decentralized Drug Distribution,” American Journal of Hospital Pharmacy, Jun. 1983, pp. 976-978, vol. 40, American Society of Hospital Pharmacists. |
Dart, Luann, “Digital Doses” Rural Electric, Jan. 2005—pp. 28-31. |
Deborah J. Mayhew, “Principles and Guidelines in Software user Interface Designs,” 1992, selected portions of Chapter 9, 17 pages, Prentice-Hall, Inc. |
Defendants Initial Invalidity Contentions with Exhibits A and B dated Sep. 8, 2014; Civil Action No. 1:14-cv-00222. |
Dennis D. Cote et al., “Robotic system for i.v. antineoplastic drug preparation: Description and preliminary evaluation under simulated conditions,” American Journal of Hospital Pharmacy, Nov. 1989, pp. 2286-2293, vol. 46, American Society of Hospital Pharmacists. |
Donna Young; “Loan repayments help pharmacists provide care in medically underserved areas,” American Journal of Health-System Pharmacy; Nov. 1, 2003, pp. 2186-2188, vol. 60. |
Environmental Scan of Pharmacy Technicians; M. MacInnis; Canadian Pharmacists Association; Sep. 2001. |
Exhibit 1, Publications Manually Reviewed for the Search to U.S. Pat. No. 8,347,887 titled “System and Method for Remotely Supervising and Verifying Pharmacy Functions” As of Jun. 25, 2014. |
Exhibit 1001 U.S. Pat. No. 8,374,887, Alexander issued Feb. 12, 2013. |
Exhibit 1002 Patent File History U.S. Pat. No. 8,374,887. |
Exhibit 1003, Declaration of Mr. Brian T. Hart from U.S. Pat. No. 8,374,887. |
Exhibit 1004, Declaration of Wayne H. Grant from U.S. Pat. No. 8,374,887. |
Exhibit 1005, 22 TAC §§291.20, 291.36, and 291.71-291.74 date issued Mar. 5, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1006 U.S. Pat. No. 6,711,460 Reese issued Mar. 23, 2004 from U.S. Pat. No. 8,374,887. |
Exhibit 1009, Peterson et al., The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities; the journal of Pharmacy Technology, vol. 20, No. 1, Jan./Feb. 2004—pp. 1-39 from U.S. Pat. No. 8,374,887. |
Exhibit 1010, Declaration of Benjamin E. Weed from U.S. Pat. No. 8,374,887. |
Exhibit 1011, Complaint—Alexander v. Baxter, (W.D.Texas 2014) filed Mar. 13, 2014 from U.S. Pat. No. 8,374,887. |
Exhibit 1012, Charles F. Seifert et al., “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education, 2004; 68 (3) Article 60—pp. 1-9 from U.S. Pat. No. 8,374,887. |
Exhibit 1013, Assignment Emily H. Alexander to Becton, Dickinson and Company; U.S. Appl. No. 13/747,231; Reel 034110/Frame 0789 from U.S. Pat. No. 8,374,887. |
Exhibit 1014, Exhibit A—Corrected Parties' Claims Construction Terms, Proposed Construction and cites Civil, 1:14cv-00222-LY—pp. 1-7 from U.S. Pat. No. 8,374,887. |
Exhibit 1015, Information about Telepharmacy presentation 42503 and Presentation Telepharmacy at Texas Tech; Jon Phillips—1-27 from U.S. Pat. No. 8,374,887. |
Exhibit 1017, Declaration of Dr. Roger W. Anderson in Support of Becton, Dickinson & Company's Response to Baxter's Motion for Summary Judgment of Invalidity Based Upon 35 U.S.C. § 101 filed Jan. 15, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1018, Plaintiff's Claim Construction Brief, 1:14-cv-222-LY filed Oct. 17, 2014 from U.S. Pat. No. 8,374,887. |
Exhibit 1019, Plaintiff's Reply Claim Construction Brief, 1:14-cv-222-LY filed Nov. 7, 2014 from U.S. Pat. No. 8,374,887. |
Exhibit 1020, The United States Pharmacopeia—the Official Compendia of Standards; 2004 from U.S. Pat. No. 8,374,887. |
Exhibit 1021, Curriculum Vitae of Brian T Hart from U.S. Pat. No. 8,374,887. |
Exhibit 1022, Curriculum Vitae of Wayne H Grant—Expert oversight—Expert Witness—Litigation Support from U.S. Pat. No. 8,374,887. |
Exhibit 1023, Charles D Peterson et al., “The North Dakota Telepharmacy Project: Restoring and Retaining Pharmacy Services in Rural Communities,” J Pharm Technol, 2004; vol. 20—pp. 028-039 from U.S. Pat. No. 8,374,887. |
Exhibit 1025, Affidavit of Christopher Butler with attached Telemedicine Report Archive dated Mar. 4, 2015—6 pages from U.S. Pat. No. 8,374,887. |
Exhibit 1026, Affidavit of Christopher Butler with attached presentation Telepharmacy at Text Tech—Jon Phillips dated Mar. 4, 2015—31 pages from U.S. Pat. No. 8,374,887. |
Exhibit 1027, Order on Motion for Summary Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1028, Final Judgment filed Aug. 3, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1029 Charles Seifert from U.S. Pat. No. 8,374,887. |
Exhibit 1030 Deposition of Charles Seifert Dec. 4, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1031 Deposition of Diane B. Ginsburg, PhD. Dec. 16, 2015 from U.S. Pat. No. 8,374,887. |
Exhibit 1032 Texas Administrative Code, Title 22, Chapter 291, Subchapter A, Section 291.23 as in effect on Feb. 1, 2004 from U.S. Pat. No. 8,374,887. |
Felkey, Bill G., “Integrating Technology at the Point of Care”, Insight, Jan. 2004—pp. 8-10. |
Formula for Patient Safety; ScriptPro; Aug. 17, 2003. |
Fred Puckett, “Medication-management component of a point-of-care information system,” Am. J. Health-Syst.Pharm., Jun. 15, 1995, pp. 1305-1309, vol. 52, American Society of Health-System Pharmacists, Inc. |
“GE ImageQuant TL 7.0 Image Analysis Software” User Manual , May 2007, http://nba.uth.tmc.edu/Assets/pdf/otherityphoon-supporting-files/IQTL-UserManual.pdf, Uppsala, Sweden. |
Gerald E. Meyer et al., “Use of bar codes in inpatient drug distribution,” Am. J. Hosp. Pharm., May 1991, pp. 953-966, vol. 48, American Society of Hospital Pharmacists, Inc. |
Ghent, Natale, “Pharmacists go digital to fight shortage”, Pharmacy Practice 20.11 (Nov. 2004): 47—2 pages. |
Gilad J. Kuperman, M.D. et al., “Innovations and research review: The impact of the HELP computer system on the LDS Hospital paper medical record,” Topics in Health Record Management, 1991, pp. 76-85, vol. 12, Issue 2, Aspen Publishers, Inc. |
“Global Med Announces First SAFETRACE TX™ Sale,” Apr. 1, 1999, 2 pages. |
Global Med Technologies, Inc. Introduces PeopleMed™.com, inc., A Chronic Disease Management Application Service Provider (ASP) Subsidiary, Jan. 11, 2000, 2 pages, Global med Technologies, Inc., Denver, CO. |
Gretchen A. Barry et al., “Bar-code technology for documenting administration of large-volume intravenous solutions,” American Journal of Hospital Pharmacy, Feb. 1989, pp. 282-287, vol. 46, American Society of Hospital Pharmacists. |
H. Paul Hammann et al., “A World Wide Web Accessible Multi-Species ECG Database,” 1997, pp. 7-12, ISA. |
Halverson, Daniel R. IsoRx: TelePharmacy Software presentation—23 pages. |
Henry J. Lowe et al., “WebReport: A World Wide Web Based Clinical Multimedia Reporting System,” 1996, pp. 314-318, AMIA, Inc. |
“Hospitals battle errors with bar codes,” Mar. 24, 2004, 3 pages, MSNBC. |
Howard L. Bleich et al., “Clinical Computing in a Teaching Hospital,” Use and Impact of Computers in Clinical Medicine, 1987, pp. 205-223 and selected pages, Springer-Verlag, New York, NY. |
http://isorx.com/ Jan. 29, 2004. |
http://www.scriptpro.com/products//sp-200/main.htm, Feb. 13, 2004, Product listing for SP 200® Robotic Prescription Dispensing System. |
http://www.scriptpro.com/products/space/space200.htm, Feb. 10, 2004, Product listing for SP Automation Center 200TM (Space 200TM) Prescription Dispensing Automation Center. |
Hughes, Shirley, “ Bedside Terminals: Clinicom,” Clinical Computing, Jan./Feb. 1988, pp. 22-28, vol. 5, No. 1. |
IPR Decision Paper No. 8 Entered Aug. 13, 2015 from U.S. Pat. No. 8,374,887. |
IPR Final Written Decision Paper No. 29 Entered Jul. 11, 2016 from U.S. Pat. No. 8,374,887. |
James Kazmer et al., “The Creation of Virtual Electronic Medical Record,” 1996, 17 pages. |
Jennifer Langham; “Taking Automation to New Levels,” Insight, the QS/1 Magazine, Oct. 2002; pp. 2-5. |
John Frady; “What's New in RxCare Plus 17.2,” Insight, the QS/1 Magazine, Apr. 2002; pp. 2-3, 14. |
Jones, et al., “Use of a remote computerized system for study documentation in clinical trials” Drug Information Journal, Oct.-Dec. 1998, vol. 32, No. 4 oe pp. 1153-1163. |
Karen E. Bradshaw et al., “Physician decision-making—Evaluation of data used in a computerized ICU,” International Journal of Clinical Monitoring and Computing, 1984, pp. 81-91, vol. 1, Martinus Nijhoff Publishers, Netherlands. |
Kastango, Eric S. and Bradshaw, Brian D., “USP chapter 797: Establishing a practice standard for compounding sterile preparations in pharmacy” Am J Health-Syst Pharm., Sep. 15, 2004, vol. 61—pp. 1928-1938. |
Kenneth N. Barker et al., “Effect of an automated bedside dispensing machine on medication errors,” American Journal of Hospital Pharmacy, Jul. 1984, pp. 1352-1358, vol. 41, No. 7, American Society of Hospital Pharmacists. |
Keeys, Christopher A. et al., “Providing nighttime pharmaceutical services through telepharmacy” Am J Health-Syst Pharm, Apr. 15, 2002, vol. 59—pp. 716-721. |
Khan, Shamima et al., “Is There a Successful Business Case for Telepharmacy?” Telemedicine and e-Health, vol. 14, No. 3, Apr. 2008, pp. 235-245. |
Kimber, Michael B. et al., “Telepharmacy-Enabling Technology to Provide Quality Pharmacy Services in Rural and Remote Communities” Journal of Pharmacy Practice and Research, vol. 36, No. 2, 2006—128-133. |
Kodak DirectView PACS—Rural Hospital Joins the Big Leagues PACS/Enterprise Information management (EIM) Solution—www.kodak.com/go/medical—4 pages. |
Kosub, David, “Device allows pharmacy care in remote areas” Pharmacy Practice, vol. 20, No. 10, Oct. 2004—pp. 12-13. |
Koutnik, Eileen, Assistnat Editor, Pharmacy Times, “The Pharmacy of Tomorrow” Pharmacy Times, Aug. 1, 2003—3 pages. |
Larry B. Grandia, B.S.E. et al., “Building a computer-based Patient Record System in an Evolving Integrated Health System,” First Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1995, pp. 19-55, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
Lefkowitz, Sheldon et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System,” 1991, pp. 239-242, Hospital Pharmacy, vol. 26. |
LP, “ATM-STyle Drug Dispensers Taking Hold in Areas With Limited Pharmacist Services” Pharmacy Practice News, Jan 2004, vol. 31, No. 1—4 pages. |
“The Longitudinal Clinical Record: A View of the Patient,” taken from Proceedings of the 1994 Annual HIMSS Conference, Feb. 14, 1994, pp. 239-250, Healthcare Information and Management Systems Society, Chicago, Illinois, USA. |
Lustig, Ahuva, “Medication error prevention by pharmacists—An Israeli solution” Pharmacy World & Science, 2000, vol. 22, No. 1—pp. 21-25. |
Medicaid Memo—Department of Medical Assistance Services (Converting NDCs from 10-digits to 11-digits) May 31, 2007. |
Medcin® Technical Overview, undated, 111 pages, Medicomp Systems. |
Michael H. Mackin, “Impact of Technology on Environmental Therapeutic Device Design,” Medical Instrumentation, Feb. 1987, pp. 33-35, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation. |
Michelle M. Casey, M.S., Jill Klingner, R.N., M.S., and Ira Moscovice, Ph.D.; “Access to Rural Pharmacy Services in Minnesota, North Dakota, and South Dakota,” Working Paper Series, Jul. 2001, #36. |
Monane et al., “Improving Prescribing Patterson for the Elderly Through an Online Drug Utilization Review Intervention”, JAMA, Oct. 14, 1998, vol. 280, No. 14—pp. 1249-1252. |
Morris, Aisha M., Schneider, Philip J., Pedersen, Craig A. and Mirtallo, Jay M. “National survey of quality assurance activities for pharmacy-compounded sterile preparations” Am J Health-Syst Pharm, Dec. 15, 2003, vol. 60—pp. 2567-2576. |
Murray, Michael D. et al. “Effects of Computer-based Prescribing on Pharmacist Work Patterns” Journal of the American Medical Informatics Association, Nov./Dec. 1998, vol. 5, No. 6—pp. 546-553. |
Napoli, M. et al., “Picture archiving and communication in radiology”, Rays. Jan.-Mar. 2003—PubMed—NCBI http://www.ncbi.nlm.m=nih.gov/pubmed/14509181—Abstract. |
Nissen et al., Can telepharmacy provide pharmacy services in the bush, School of Pharmacy, University of Queensland, Brisbane, Australia, Journal of Telemedicine and Telecare 2003, vol. 9 (Suppl. 2): S2:39-41. |
North Dakota Century Code Statute Law—State Board of Pharmacy—219 pages. |
Parks, Liz, “Annual report of retail pharmacy: Using central-fill to maximize dispensing” Drug Store News, Aug. 20, 2001 vol. 24, No. 11—pp. 51, 75. |
Parsons, et al., “Digital Media—Can I Change a Graphic's File Size?”, New Perspectives on Computer Concepts—Course Technology, 2011, Cengage Learning, Boston, MA. |
Paul H. Perlstein et al., “Computer-Assisted Newborn Intensive Care,” Pediatrics, Apr. 1976, pp. 494-501, vol. 57, No. 4, American Academy of Pediatrics, Inc., Evanston, Illinois. |
Paul H. Perlstein et al., “Future Directions for Device Design and Infant Management,” Medical Instrumentation, Feb. 1987, pp. 36-41, vol. 21, No. 1, Association for the Advancement of Medical Instrumentation. |
PCA II Multi-Mode Cartridge Operator's Manual, Sep. 1995, approx. 40 pages, Baxter Healthcare Corporation, Deerfield, IL. |
Pesce, James, “Bedside Terminals: Medtake,” Clinical Computing, Jan. /Feb. 1988, pp. 16-21, vol. 5, No. 1. |
Peter Lord et al., MiniMed Technologies Programmable Implantable Infusion System, Annals New York Academy of Science, pp. 66-71, describing clinical trials from Nov. 1986. |
Peterson et al., The North Dakota Telepharmacy Project Restoring and Retaining Pharmacy Services in Rural Communities—Presentation North Dakota State University, Fargo, North Dakota. |
Petition for Inter Partes Review Baxter International Inc. v. Becton, Dickinson and Company for U.S. Pat. No. 8,374,887, pp. 1-69. |
Pharmacy Automation ONLINE Vendors Page; Internet Archive Wayback Machine; http://pharmacyautomation.com/vendors.html—3 pages. |
Pharmacy Data Management (PDM) Technical Manual/Security Guide Version 1.0, Sep. 1997—55 pages. |
Pharmacy education and practice out of sync? (Roundtable) Chain Drug Review, vol. 25, No. 6, Mar. 17, 2003, RX2 (6). |
Prem S. Chopra, Virgil A. Thomason, and Dell M. Stinett; “Voice-Activated Networked Workstation for a Physically Disabled Physician,” 10-7803-2050-6/94 1994 IEEE, pp. 478-479. |
Product literature, Baxter Healthcare Corporation, “Flo-Gard® 6201 Volumetric Infusion Pump,” 1992, 2 pages. |
Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” 1988, 2 pages. |
Product literature, Baxter Healthcare Corporation, “MultiPlex™ Series 100 Fluid Management System,” undated, 2 pages. |
Remote Dispensing Regulations, NABPLAW Sep. 2003. |
Woodall, Sandra C., Remote Order Entry and Video Verification; Reducing After-Hours Medication Errors in a Rural Hospital; S. Woodall; Joint Commission on Accreditation of Healthcare Organizations; vol. 30; No. 8; Aug. 2004. |
Rich Muller; “NRx QS/1's Premium Pharmacy Software,” Insight, the QS/1 Magazine, Jul. 2003; pp. 2-3, 12-15. |
Rouse, et al., Academy of Managed Care Pharmacy et al., “White paper on pharmacy technicians 2002: Needed changes can no longer wait” Am J Health-Syst Pharm, Jan. 1, 2003, vol. 60—pp. 37-51. |
Rule Section 291.36—Class A Pharmacies Compounding Sterile Pharmaceuticals—1 page. |
Schrenker, Richard and Cooper, Todd, “Building the Foundation for Medical Device Plug-and-Play Interoperability”. |
Seifert et al.; “The Training of a Telepharmacist: Addressing the Needs of Rural West Texas,” American Journal of Pharmaceutical Education 2004; 68 (3) Article 60. Jul. 16, 2004. |
Standard Specification for Transferring Clinical Laboratory Data Messages Between Independent computer Systems, Annual Book of ASTM Standards, Mar. 25, 1988, pp. 1-16, E 1238-88, Global Engineering Documents, Philadelphia, PA. |
Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Annual Book of ASTM Standards, Jun. Mar. 1994, pp. 132-210, E 1238-94, Philadelphia, PA. |
Standard Specification for Transferring Clinical Observations Between Independent Computer Systems, Aug. 10, 1997, 79 pages, ASTM E 1238-97, West Conshohocken, PA, United States. |
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Annual Book of ASTM Standards, Jun. 1991, 15 pages, E 1394-91, Philadelphia, PA. |
Suzanne Carter, RN, Ed.D. et al., “The Computer-based Patient Record: The Jacobi Medical Center Experience,” Second Annual Nicholas E. Davies Award Proceedings of the CPR Recognition Symposium, 1996, pp. 71-95, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
T. Allan Pryor et al., “help—A Total Hospital Information System,” Proceedings of the Fourth Annual Symposium on Computer Applications in Medical Care, Nov. 2-5, 1980, pp. 3-7, vol. 1, Institute for Electrical and Electronics Engineers, New York, NY. |
T.E. Bozeman et al., “The Development and Implementation of a Computer-Based Patient Record in a Rural Integrated Health System,” Third Annual Nicholas E. David Award Proceedings of the CPR Recognition Symposium, 1997, pp. 101-130, Computer-based Patient Record Institute, Inc., Bethesda, MD. |
“Telepharmacy project expands students' practice experience” Telemedicine Report, vol. 6, No. 1, Jan. 2004 oe 4 pages. |
The World's First Fully Integrated Workflow Manager for I.V. Rooms, IntelliFlowRx Brochure, For Health Technologies Inc,. United States, May 2008. |
Title 22. Examining Boards, 22 TAC Section 1.161; texinfo.library.unt.edu/Texasregister/html/2001/sep-14/PROPOSED/22.EXAMING BOARDS.html—Sep. 20, 2014, pp. 1-70. |
Ukens, Carol, “Pharmacist shortage boosts telepharmacy” Drug Topoics, Jun 3, 2002; 146, 11—p. 53. |
Valeriy Nenov et al., “Remote Analysis of Physiological Data from Neurosurgical ICU Patients,” Journal of the American Medical Informatics Association, Sep./Oct. 1996, pp. 318-327, vol. 3, No. 5. |
“Victor J. Perini et al.,”“Comparison of automated medication-management systems,: Am. J. Hosp. Pharm., Aug. 1, 1994, pp. 1883-1891, vol. 51, American Society of Hospital Pharmacists, Inc.”. |
Vincenzo Della Mae et al., “HTML generation and semantic markup for telepathology,” Computer Networks and ISDN Systems, 1996, pp. 1085-1094, vol. 28, Elsevier Science B.V. |
Website information for Cartharsis Medical Technology Products, Dec. 9, 2001, 15 pages. |
Website information for MedPoint™, Mar. 13, 2003, 20 pages, Bridge Medical, Solana Beach, CA. |
William R. Dito et al., “Bar codes and the clinical laboratory: adaptation perspectives,” Clinical Laboratory Management Review, Jan./Feb. 1992, pp. 72-85, Clinical Laboratory Management Association, Inc. |
Wills, Robert D., “Drug Images and Drug Imprints” Insight, Apr. 2001—p. 7. |
Yvonne Mari Abdoo, “Designing a Patient Care Medication and Recording System that Uses Bar Code Technology,” Computers in Nursing, May/Jun. 1992, pp. 116-120, vol. 10, No. 3. |
Jon Phillips, Telepharmacy at Texas Tech, PowerPoint, Jan. 26, 1997, https://web.archive.org/web/20040509162423/http:/www.ttuhsc.edu/telemedicine/Powerpoint/Telepharmacy%20presentation%2042503.ppt. |
A.H. McMorris et al. “Are Process Control Rooms Obsolete?”, Control Engineering, pp. 42-47, Jul. 1971. |
Standard Specification for Transferring Clinical Observations between Indepdendent Computer Systems, Annual Book of ASTM Standards, Nov. 14, 1991, pp. 1-64, ASTM E 1238-91,Philadelphia, PA. |
Standard Specification for Transferring Information Between Clinical Instruments and Computer Systems, Dec. 10, 1997; 15 pages, ASTM E 1394-97, West Conshohocken, PA, United States. |
Web site information, Information Data Management, Inc.'s PCMS: Plasma Center Management System, Dec. 14, 2001, 11 pages. |
Web site Information, Wyndgate Technologies' SafeTrace Tx™, undated, 15 pages. |
Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems, Mar. 11, 1991; 7 pages, ASTM E 1381-91, Philadelphia, PA, United States. |
Atherton, H.D., Dollberg, S., Donnelly, M.M., Perlstein, P. H. Roath, S.B., “Computerized Temperature Control of the Low-Birth-Weight Infant: A 20-Year Retrospective and Future Prospects,” Biomedical Instrumentation and Technology, Jul./Aug. 1994, pp. 302-309, vol. 28 No. 4. |
Friesdorf, W., Grob-Alltag, F., Konichezky, S., Schwilk, B., Fattroth, A., Fett, P., “Lessons learned while building an integrated ICU workstation,” International Journal of Clinical Monitoring and Computing, 1994, pp. 89-97, vol. 11. |
Gammon, K., Robinson, K., “Bedside Data System Aids Pharmacy,” Computers in Healthcare, Dec. 1988, pp. 3537, vol. 9 No. 12. |
Graseby 3100 Syringe Pump, Graseby Medical Ltd., A Cambridge Electronic Industries Company, England, 2 pages. |
Kampmann, J., Lau, G., Kropp, ST., Schwarzer, E., Hernandez Sande, C., “Connection of electronic medical devices in ICU according to the standard ‘MIB’,” International Journal of Clinical Monitoring and Computing, 1991, pp. 163-166, vol. 8. |
Angaran, “Telemedicine and telepharmacy: Current status and future implications”, Am J Health-Syst Pharm, vol. 56, Jul. 15, 1999 (32 pages). |
Carson, Ewart et al., “A Systems Methodology for the Development and Evaluation of a Telematic Home Haemodialysis Service,” Proceedings—19th International Conference—IEEE/EMBS Oct. 30-Nov. 2, 1997, Chicago, Illinois, pp. 907-910. |
Number | Date | Country | |
---|---|---|---|
20160180057 A1 | Jun 2016 | US |
Number | Date | Country | |
---|---|---|---|
62088358 | Dec 2014 | US |